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ABSTRACT
Introduction
Sleep Disordered Breathing (SDB) during pregnancy is associated with maternal and
neonatal morbidity, and in-hospital mortality. A recent prevalence study using the
Nationwide Inpatient Sample reported an obstructive sleep apnea (OSA) prevalence of
7.3 per 10,000 in 2013, a rate of 24% per year over the last decade. The rise in prevalence
mirrors the rise in obesity. Military Treatment Facilities (MTF) have seen an increase in
obesity and related co-morbidities with an unknown prevalence of SDB. Most studies
have been conducted in high-risk populations; the general prevalence of SDB and its
association with adverse pregnancy outcomes in a military population needs exploration.
Methods
This prospective, observational study used the Facco Four Variable (FFV) model and
STOP-Bang to screen parturients presenting for delivery at a MTF to determine the
general prevalence of SDB. Logistic regression on parturient data who screened positive,
FFV (score ≥75) and STOP-Bang (score ≥ 3) was used to examine if higher rates of
adverse pregnancy outcomes (gestational hypertension, preeclampsia/eclampsia,
gestational diabetes, non-elective cesarean delivery, NICU admission, hospital stay >5
days, a composite variable of adverse pregnancy outcomes) were associated with SDB.
Demographic and prevalence data were compared between active duty and non-active
duty participants.

Results
Of the study population (N=295), the FFV identified 12.3% (n=36) and STOP-Bang
7.1% (n=21) participants at high risk for SDB. Adverse pregnancy outcomes were
experienced by 58% women with the FFV and 66% with STOP-Bang. Logistic
regression indicated the FFV categorical score (≥75) was not predictive of adverse
pregnancy outcomes. Utilizing FFV absolute score, an increased risk of APO was noted
(adjusted OR=1.03, 95% CI 1.01-1.05, p=.013). Logistic regression indicated a STOPBang score ≥3 was predictive of an adverse pregnancy outcome (adjusted OR=3.26, 95%
CI 1.23-8.62, p=.018).
Conclusion
Findings support the need for routine screening for identification of SDB during
pregnancy and the opportunity for repeated testing to track progression, treatment, and
resolution of SDB. Further research is needed to determine critical points in the
development and management of SDB during pregnancy, if and when SDB resolves after
delivery, and the long-term health effects for both mother and child.
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CHAPTER I
INTRODUCTION
Sleep Disordered Breathing (SDB) is a not-so-silent syndrome that is largely
undiagnosed, yet has significant implications for health. SDB is often associated with
loud snoring, older men, and obesity but there is another population who may be at
significant risk: pregnant women. Pregnancy has been associated with alterations in sleep
that may come from a number of causes, including SDB (August et al., 2013). There is
mounting evidence SDB plays a significant role in the morbidity and mortality of
perinatal outcomes directly involving the nurse anesthetist. For nurse anesthetists, factors
associated with SDB, for instance, obesity, preeclampsia, diabetes, difficult intubation,
cesarean delivery, and sensitivity to anesthetic agents, sedatives, and hypnotics can
complicate anesthetic care (Chung, Yuan, & Chung, 2008). Screening for SDB may alert
the anesthetist to underlying factors that can contribute to an adverse outcome and
provide essential information to change the anesthetic plan. A confluence of variables
directly related to the anesthetic plan such as medications and side effects, sleep
deprivation and fatigue, and lack of monitoring protocols may be placing our patients at
risk for such catastrophic outcomes as respiratory depression and death. Obesity and
hypertensive disorders intertwined with SDB may be contributing to cesarean deliveries,
pre-term deliveries, and low birth weights. Unrecognized and undiagnosed SDB during
the antenatal time frame may lead to adverse pregnancy outcomes. Without screening for
SDB in pregnancy we may be overlooking a significant contributor to morbidity and
mortality in pregnancy.
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Background
Obesity is perhaps the strongest correlate with SDB across all populations.
Alarmingly, a recent study predicts a 33% increase in the prevalence of obesity over the
next two decades (Finkelstein et al., 2012). Excess body weight and fat accumulation can
work in several ways to develop SDB. Fat accumulation can alter upper airway structure,
increase total body oxygen demand, and decrease functional residual capacity–all of
which can promote or exacerbate SDB (Young, Peppard, & Gottlieb, 2002). Obesity
during pregnancy has been associated with increased risk for gestational diabetes,
preeclampsia, cesarean delivery, macrosomia, low Apgar scores, and still birth (Ovesen,
Rasmussen, & Kesmodel, 2011). Excess weight gain before or during pregnancy over
and above Institute of Medicine recommendations is also an independent predictor of
preeclampsia (O’Brien et al., 2012). The prevalence of SDB among pregnant women has
risen dramatically, 24% per year over the past decade, and coincides with the rise in
obesity rates (J. M. Louis, Mogos, Salemi, Redline, & Salihu, 2014). Similar to obesity,
SDB is associated with maternal morbidities such as chronic hypertension and diabetes
mellitus in addition to asthma and depression (Louis, Auckley, Sokol, & Mercer, 2010).
Obesity and SDB have similar risks for the neonate such as NICU admission (J. Louis,
Auckley, Miladinovic, et al., 2012), pre-term birth, and cesarean delivery (Bourjeily,
Ankner, & Mohsenin, 2011). The commonality of such adverse pregnancy outcomes as
gestational diabetes, preeclampsia, cesarean delivery, pre-term delivery, and NICU
admission is concerning based on what we already know about the prevalence of obesity
and what we are learning about the rising prevalence of SDB.
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Unlike the obstetrician who may have the benefit of establishing a relationship
and monitoring co-morbidities over several months of the pregnancy, the anesthetist may
only meet the patient shortly before delivery. Sleep disordered breathing is associated
with co-morbidities such as obesity, preeclampsia, diabetes, difficult intubation, cesarean
delivery, and sensitivity to anesthetic agents, sedatives and hypnotics – all of which can
complicate anesthetic care. The sensitivity to anesthetic agents, sedatives, and hypnotics
is of particular interest. With a limited window of opportunity to address co-morbidities,
the nurse anesthetist may be left with few options other than to alter the anesthetic
technique by reducing the amount of narcotic medications the patient receives–a critical
component of pain management.
A large percentage of obstetric anesthesia practice is centered on providing
neuraxial anesthesia in the form of spinal and epidural solutions of local anesthetic and
narcotic medications. Preservative-free morphine has been approved for neuraxial
administration for post-operative analgesia since 1984 and has been used extensively
(Sultan et al., 2011). However, there is the potential adverse effect of respiratory
depression that is significantly concerning. The pharmacokinetics of opioids can be
complex, especially when comparing interactions or differences between compartments
such as spinal or epidural and plasma. Epidural pharmacokinetics are especially
challenging as they may vary by level of insertion (Sultan et al., 2011). Level of insertion
may vary depending upon patient positioning and anesthesia provider technique. The
incidence and degree of respiratory depression from neuraxial administration of
preservative-free morphine is difficult to ascertain in the perinatal period due to
intermittent monitoring of vital signs–a practice that is often unreliable in predicting
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respiratory depression (Carvalho, 2008). Screening for SDB may provide additional
information to the nurse anesthetist that can be used to alter the anesthetic plan. Narcotic
dosing with spinal anesthetics may be decreased or eliminated based on concerns for
SDB and a need for additional monitoring. Alternative pain management plans such as
non-narcotic pain medications and transverse abdominal plane regional anesthesia blocks
may be used. A study evaluating sleep in the five nights prior to delivery and early labor
found women with less total sleep time (TST) the night before birth had higher total pain
scores during labor (Beebe & Lee, 2007). Sleep deprivation may impact the ability to
tolerate labor pain and could change the timing and duration of epidural pain
management. Early initiation of an epidural or replacement of a poorly performing one
based on a risk assessment of SDB may be appropriate. If general anesthesia is required,
a provider may make extra preparations to prepare for a difficult airway or to decide
when to extubate. Additional resources and supportive therapies such as continuous
positive airway pressure (CPAP) and continuous end-tidal carbon dioxide (ETCO2)
monitoring may be required. Depending upon the hospital or birthing facility size,
resources for both mother and child may not be sufficient. Transfer of care may be
required to a facility with a NICU and continuous monitoring capability. Not knowing
about a condition like SDB and how it interacts with so many crucial aspects of
anesthesia may be the most dangerous situation of all.
Purpose and Specific Aims
The purpose of this study was to examine the prevalence of Sleep Disordered
Breathing (SDB) and its association with adverse pregnancy outcomes in pregnant
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women at delivery using the Facco Four Variable model and the STOP-Bang model at a
large Military Treatment Facility (MTF). This was achieved through the following aims.

Aim 1: To examine the prevalence of SDB using a cut-score of ≥75 on the
Facco Four Variable model and a score ≥ 3 on the STOP-Bang model in a
general obstetric population admitted in the immediate postpartum period
at a large academic Military Treatment Facility.
Aim 2: To examine if parturients suspected of having SDB as assessed by the
Facco Four Variable Model (FFV; score ≥75) or the STOP-Bang (SB;
score ≥ 3) have higher rates of the following adverse maternal child
outcomes: gestational hypertension, low birth weight <2500 gms, NICU
admission, Preterm delivery <37 weeks gestation, preeclampsia/eclampsia,
gestational diabetes, cesarean delivery, hospital stay >5 days, a composite
score of adverse pregnancy outcomes, and a composite score of
cardiopulmonary complications that includes pulmonary embolism, inhospital mortality, pulmonary edema, congestive heart failure, and
cardiomyopathy.
Aim 3-Exploratory: Compare the prevalence rates of suspected SDB at delivery
between active duty and non-active duty parturients.
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Theoretical Perspective
Pregnancy is a time of almost unprecedented change in a woman’s life. When
viewed through the lens of nursing science (person, environment, health, and illness) all
aspects undergo significant alterations in a relatively short amount of time. The physical
and physiologic changes produce a wide range of symptoms that occur throughout the
pregnancy and can vary from day to day. Symptoms can range from the obvious, such as
an increase in physical size to an insidious rise in blood pressure. Multiple symptoms
may be present at any time and arise from multiple conditions. As a woman experiences
symptoms she must perceive, evaluate, and manage the symptom appropriately.
Symptom Management Theory (SMT) was used to guide the study (Humphries et
al., 2008). There are three essential concepts that comprise SMT: symptom experience,
symptom management strategies, and symptom status outcomes. Symptom experience is
the simultaneous perception, evaluation, and response to a change in how one usually
feels. Symptom management is the effort to avert, delay, or minimize the symptom
experience. Symptom status outcomes are measures of how effective the symptom
management was at decreasing the perceived symptom (Humphries et al., 2008).
As mentioned previously, there are a number of symptoms of pregnancy. Specific
to SDB, snoring and daytime sleepiness are symptoms that may develop at any time and
worsen throughout the pregnancy. These symptoms may present a challenge to manage.
Snoring may not be noted if a woman lacks a sleep partner or may be perceived as a sign
of deep sleep– a confusing result when experiencing excessive daytime sleepiness.
Arousal and sleep fragmentation may result from SDB but be associated with other
physical discomforts and an inability to enter a restful state. Cultural expectations of
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fatigue during pregnancy may mask an underlying physiologic cause. The use of SMT
guides the patient and provider to explore the symptoms of snoring and excessive
daytime sleepiness, screen and test for SDB, explore options to manage the symptoms
(minimize weight gain, airway support therapies), and assess management progress with
testing (at home sleep study). Through identification and management of the symptoms
of SDB definitive action can be taken to minimize or alleviate the impact of SDB on the
pregnancy and ultimately improve the outcome.

Figure 1. Model of Symptom Management Theory
7

Implications for Nursing Research
Disturbance of sleep during pregnancy is not a new phenomenon but the
relationship between poor sleep and adverse pregnancy outcomes is gaining attention.
Traditional assumptions and tolerance of poor sleep during pregnancy needs to be
examined through nursing science. While the time span of pregnancy may be short
relative to a person’s life span, the stresses and changes that occur may have a greater
impact on future health than is currently understood. Kestenbaum et al. (2003) examined
cardiovascular and thromboembolic events after a hypertensive pregnancy. All singleton
births in Washington State from 1987 to 1989 were examined for diagnosis of gestational
hypertension, preeclampsia, chronic hypertension, and then linked to later hospital
admissions. The results showed an increased risk for cardiovascular events such as acute
myocardial infarction, stroke, deep vein thrombosis, coronary artery revascularization,
and pulmonary embolism. The associations are as follows: gestational hypertension 2.8
(95% CI, 1.6-4.8), mild preeclampsia 2.2 (95% CI, 1.3-3.6), and severe preeclampsia 3.3
(95% CI, 1.7-6.5). Women with hypertensive disorders during pregnancy are at 2-3 times
greater risk for the development of significant cardiovascular events later in life.
During a pregnancy, a woman will have multiple exposures to nurses and
numerous opportunities to be engaged on issues of her health-both short and long term.
The knowledge and information from these interactions can shape the future health of a
family. Nursing research is well prepared to provide the science to support these families
for a lifetime of good health.
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CHAPTER II
LITERATURE REVIEW
Pregnancy has been associated with alterations in sleep that may come from a
number of causes, including Sleep Disordered Breathing (SDB). There is mounting
evidence SDB plays a significant role in the morbidity and mortality of perinatal
outcomes. Sleep disordered breathing is a broad term covering a spectrum of disorders
that effect breathing while sleeping and have a range of physiologic consequences.
Obstructive sleep apnea (OSA) is a specific form of sleep disordered breathing with
periods of apnea, oxygen desaturation, excessive daytime sleepiness, and snoring that
result from airway obstruction (J. Louis, Auckley, Miladinovic, et al., 2012; Quan et al.,
1997). The airway obstruction is from a combination of anatomic and neuromuscular
factors that in turn are influenced by age, gender, and body habitus (Young, Peppard, &
Gottlieb, 2002). During pregnancy, a woman may be more likely to develop SDB and
experience perinatal complications.
History
A review of the literature reveals sleep apnea syndromes have been an area of
inquiry since the 1970’s (Guilleminault, Tilkian, & Dement, 1976). Research into the
causes of cardiovascular disease developed links to SDB. Large population studies for
SDB began and have been instrumental in forming the body of knowledge about SDB
and pregnancy. Two studies of historical interest are the the Sleep Heart Health Study
(Quan et al., 1997) and Wisconsin Sleep Cohort Study (Young et al., 2008).
The Sleep Heart Health Study (SHHS) is an example of early (and ongoing)
research into links between cardiovascular disease and sleep. The study began in 1994 as
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a prospective, longitudinal, cohort design investigating cardiovascular disease and the
independent contribution of sleep apnea. Subjects were recruited from established
cardiovascular and pulmonary epidemiologic cohort studies already underway throughout
the country. All subjects were a minimum age of 40 years and predominately male;
pregnancy was not a focus. A cross sectional analysis was published to discuss interval
findings (Gottlieb, 2008). The relationship between sleep apnea and cardiovascular
disease showed hypertension strongly associated with even mild OSA and significant
changes to ventricular morphology resulting in a lower left ventricular ejection fraction.
The report also describes how the methodology of SDB research has changed as a result
of the study. The definition of an apnea-hypopnea event, a fundamental variable in SDB
research, was different based on the amount of oxygen desaturation or presence of
arousal. Oxygen desaturation could range from 2-5% and the resulting AHI would vary
from 2.0 events per hour with a 5% desaturation to 17.4 events per hour with a 2%
desaturation. This resulted in an increase in SDB prevalence of patients with an AHI >15
from 10% to over 50%. The results of this study prompted the standardization of the
methodology for diagnosing SDB by the American Academy of Sleep Medicine Manual
for the Scoring of Sleep and Associated Events.
The Wisconsin Sleep Cohort Study began in 1988 as a prospective population
based study on the natural history of SDB (Young et al., 2008). Participants were
recruited from a sampling of payroll records from state agencies of Wisconsin, were not
patients, and did not have a diagnosis of SDB. Men and women age 30-60 (n=2940)
completed a survey and were invited to participate in an overnight polysomnography
(PSG) protocol (n= 1522) and were followed for several years (mean = 13.8 years, range
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1.5-18.7). An eighteen-year follow-up finds that all-cause mortality risk increased
significantly with SDB severity (Young et al., 2008). The adjusted hazard ratio (95% CI)
for SDB vs no SDB was 3.0 (1.4, 6.3). Individuals with severe SDB had a hazard ratio
(95% CI) of 5.9 (2.6, 13.3). Having SDB, especially unrecognized or untreated,
significantly increases mortality. This study has slightly more male participants (55%),
the first exclusion criteria is pregnancy, and the enrollment of subjects 30-60 years of age
covers only a fraction of a woman’s reproductive period. The study is important in
establishing that SDB has a significant impact on cardiovascular events and life
expectancy. It also emphasizes the need to clinically recognize and treat SDB regardless
of age, sex, or BMI. By not screening, diagnosing, and treating this problem we are
putting patients at risk. The second point to be made about this study is younger women,
especially pregnant women were not included as part of the study population and there is
a growing body of knowledge that indicates they are at risk for SDB, higher mortality
during pregnancy, and later in life.
Both of these studies focused on the influence of SDB on cardiovascular events
such as hypertension and myocardial infarction with the result being a strong association.
In addition, these studies demonstrate the direction SDB research has been moving: older
adults and mostly men. Both studies are the bedrock of research into SDB and have been
instrumental in guiding subsequent research. Unfortunately, the majority of research has
been focused on studying the older, predominately male. Women of reproductive age are
underdiagnosed and understudied in regards to SDB (J. Louis, Auckley, Miladinovic, et
al., 2012).
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Theoretical Perspective
Pregnancy is a time of almost unprecedented change in a woman’s life. When
viewed through the lens of nursing science (person, environment, health, and illness) all
aspects undergo significant alterations in a relatively short amount of time. The physical
and physiologic changes produce a wide range of symptoms that occur throughout the
pregnancy and can vary from day to day. Symptoms can range from the obvious, such as
an increase in physical size to an insidious rise in blood pressure. Multiple symptoms
may be present at any time and arise from multiple conditions. As a woman experiences
symptoms she must perceive, evaluate, and manage the symptom appropriately.
Symptom Management Theory (SMT) was used to guide the study (Humphries et
al., 2008). There are three essential concepts that comprise SMT: symptom experience,
symptom management strategies, and symptom status outcomes. Symptom experience is
the simultaneous perception, evaluation, and response to a change in how one usually
feels. Symptom management is the effort to avert, delay, or minimize the symptom
experience. Symptom status outcomes are measures of how effective the symptom
management was at decreasing the perceived symptom (Humphries et al., 2008).
The symptom management model is based on six assumptions. (Dodd et al.,
2001) First, the perception of the individual experiencing the symptom is the gold
standard for the study of symptoms. The symptom does not have to be experienced by an
individual to apply the model. The individual may be at risk for the development of the
symptom and require a plan to manage the symptom at some point in the future. Nonverbal patients may experience symptoms with a caregiver interpreting the symptom for
the purpose of intervening. The management strategy may be targeted at multiple levels
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from the individual to groups or a work environment. Symptom management is a
dynamic process that is modified based on individual outcomes and the influences of
healthcare providers, the environment, and health/illness domains. Three of these
assumptions are especially important for this study. The risk for developing a symptom
(snoring, sleepiness) based on a context variable (pregnancy) directly applies. A woman
at the beginning of pregnancy may not have any symptoms of changing health or illness
but as the pregnancy progresses symptoms are bound to appear. Symptom management is
a dynamic process with constant perception, evaluation and response and is ideally suited
to the steady onset of change during pregnancy. As the fetus grows and develops,
physiology, psychology and social changes all take place. The management strategy may
include the participant’s spouse or bed partner, changes to the work environment, and
support of family members.
As mentioned previously, there are a number of symptoms of pregnancy. Specific
to SDB, snoring and daytime sleepiness are symptoms that may develop at any time and
worsen throughout the pregnancy. These symptoms may present a challenge to manage.
Snoring may not be noted if a woman lacks a sleep partner or may be perceived as a sign
of deep sleep– a confusing result when experiencing excessive daytime sleepiness.
Arousal and sleep fragmentation may result from SDB but be associated with other
physical discomforts and an inability to enter a restful state. Cultural expectations of
fatigue during pregnancy may mask an underlying physiologic cause. The use of SMT
guides the patient and provider to explore the symptoms of snoring and excessive
daytime sleepiness, screen and test for SDB, explore options to manage the symptoms
(minimize weight gain, airway support therapies), and assess management progress with
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testing (at home sleep study). Through identification and management of the symptoms
of SDB definitive action can be taken to minimize or alleviate the impact of SDB on the
pregnancy and ultimately improve the outcome.

Figure 1. Model of Symptom Management Theory
Prevalence
The prevalence of OSA in the pregnant population is not known and determining
that number is complicated due to a lack of a validated screening instrument. Using data
from the Wisconsin Sleep Cohort Study, Young et al. (1993) were able to demonstrate
14

2% of women and 4% of men in the middle-aged workforce meet minimum diagnostic
criteria for sleep apnea syndrome. The prevalence of SDB was significantly higher in
men, in all age groups, and at three AHI cut points of ≥ 5, ≥ 10, and ≥ 15 with men 2.03.7 times more likely than women to have SDB. The study population was a random
sample of Wisconsin state employees who were selected to be more likely to have SDB
based on a six question survey. The age for inclusion was a minimum of 30 years and the
first exclusion criteria was pregnancy. This is an ongoing community-based study and a
recent follow-up analysis found that the prevalence of SDB continues to rise at
substantial rates across all subgroups over the past two decades. (Peppard et al., 2013)
Using the Wisconsin Sleep Cohort Study (WSCS) data, Peppard et al (2013) developed
SDB prevalence models based on age group, sex, and weight status categories for two
time periods: the early 1990’s and late 2000’s. The prevalence model was then applied to
data over the same time periods from the National Health and Nutrition Examination
Survey (NHANES) and compared with the original data from the WSCS. The study
found that men aged 30-49 had a prevalence estimate of moderate to severe SDB (AHI ≥
15) of 10% while women in the same cohort had a prevalence of just 3%. As both groups
increased in age the prevalence increased. For men aged 50-70 the prevalence estimate of
moderate to severe SDB (AHI ≥ 15) was 17% and for women it was 9%. Based on this
information, women have roughly half the risk of developing OSA as men. However, the
study may have missed the greatest period of exposure for the development of SDB/OSA
and the associated morbidities-pregnancy.
The majority of studies of SDB in pregnancy have focused on the sub-set of the
obstetric population at greatest risk: patients with obesity, diabetes, and hypertensive
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disorders. Louis et al. (2012) investigated perinatal outcomes in obese pregnant women
with and without OSA and reported a prevalence of 15.4% (95% CI, 10.4-21.6%). A
strength of this study was that the diagnosis of SDB was confirmed by polysomnography.
Sahin et al. (2008) also investigated pregnancy outcomes related to OSA. From a small
sample of 35 pregnant women, an OSA prevalence of 11.4%, confirmed by
polysomnography, was reported. A key factor for both studies is the use of
polysomnography to confirm the diagnosis of SDB, the gold standard. Polysomnography
is expensive, cumbersome, and time consuming making it difficult to apply to larger
studies and further supports the need for less expensive, reliable, and efficient screening
measures.
The prevalence of SDB changes throughout pregnancy. Facco et al (2014)
examined a cohort of 128 pregnant women at high-risk for SDB. (Facco, Ouyang, Zee, &
Grobman, 2014) Pregnant women with any of the following were recruited: BMI > 30,
chronic hypertension, pregestational diabetes, history of preeclampsia, and/or a twin
gestation. At-home overnight sleep studies were conducted between 6-20 weeks gestation
and again between 28-37 weeks gestation. Sleep disordered breathing was defined as an
AHI ≥ 5 and categories of mild (AHI 5-14.9), moderate (AHI 15-29.9), and severe (AHI
≥ 30) were used. Participants that had an initial AHI < 5 at baseline but then had an AHI
≥ 5 in the third trimester were reported as new onset SDB. The baseline prevalence of
mild, moderate, and severe SDB was 21%, 6%, and 3%. The third trimester prevalence
for mild, moderate, and severe was 35%, 7%, and 5%. A new diagnosis of SDB was
made in 20% of the participants and 27% of participants had increased severity of SDB.

16

Sleep disordered breathing is as dynamic as pregnancy and may develop or increase in
severity throughout pregnancy.
In a recent study, Louis et al. (2014) used ICD-9 codes and the Nationwide
Inpatient Sample (NIS) database to identify Obstructive Sleep Apnea (OSA) in pregnant
women and evaluate patient outcomes. The study estimated 55 million pregnancy-related
inpatient discharges were evaluated in the United States over an 11-year period (19982009) from the NIS database were evaluated. During the first year of the study, 1998, the
prevalence of OSA in the study population was 0.7% per 10,000 population; during the
last year of the study, 2009, the prevalence rate had increased tenfold to 7.3 per 10,000
population with an annual average increase of 24.4% (95% CI, 22.1-26.8%) (J. M. Louis
et al., 2014). The annual average increase correlates strongly with a reported average
increase in clinically diagnosed obesity rate of 20%. The study results may be affected by
the general increase in knowledge of SDB and OSA as more research has been conducted
over the 11-year period. A limitation was that the authors could not confirm if women
were treated with continuous positive airway pressure therapy. However, the rise in OSA
prevalence is impressive, especially with the corresponding rate of obesity, and predicts a
major threat to health that is not being assessed on a regular basis.
Outcomes
While the prevalence of SDB varies between studies and populations and is
hindered by a lack of validated screen for use during pregnancy, there are consistent and
concerning trends in the outcomes. SDB is associated with chronic hypertension, asthma,
diabetes mellitus, and depression (J. M. Louis, Auckley, Sokol, & Mercer, 2010). During
pregnancy, OSA may be associated with preeclampsia, cesarean delivery, preterm birth,
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and increased morbidity. In a retrospective cohort study of obese and non-obese pregnant
women with OSA confirmed by polysomnography, Lewis et al. (2012) identified several
concerns. Women with OSA were more likely to have a primary cesarean delivery for
arrest of labor when compared with obese controls and normal-weight controls (19% vs.
10% and 3.5%, respectively; p <.001). Preeclampsia was also more prevalent in the OSA
group than in the normal weight controls (19.3% vs. 7%, p = .02). Preterm birth (<37
weeks) was greater in the OSA group than normal weight controls (29.8% vs. 12.3%, p
=.007). A composite morbidity factor was also evaluated as an outcome measure. The
composite factor was defined as a patient having one or more of the following: blood
transfusion, conversion from regional to general anesthesia, unexpected surgical
procedure (excluding cesarean section), postpartum endometritis, maternal sepsis,
pneumonia, wound complications, prolonged post-delivery hospital stay (≥ 3 days for
vaginal delivery, ≥ 5 days for cesarean delivery), intensive care unit admission, and/or
hospital readmission. Subjects with OSA had greater morbidity (OR 4.6, 95% CI 1.513.7) than those without. This study is unique in that all cases of OSA were confirmed by
polysomnography and matched controls of both obese and normal weight participants
were used. This study underscores the relationships between obesity, OSA, and comorbid
conditions.
Another study focusing specifically on snoring during pregnancy and delivery
outcomes reported women with SDB were at greater risk for emergency cesarean
delivery and small-for-gestational age. Obrien et al. (2013) studied 1,673 pregnant
women ≥ 18 years of age and ≥ 28 weeks pregnant to determine the effect of maternal
snoring on delivery outcomes. The study found an independent association between
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chronic, pre-pregnancy snoring and <10th birth centile (OR 1.65, 95%CI 1.02-2.66,
p=0.041). Chronic and pregnancy onset snoring are independently associated with
elective cesarean delivery (OR 2.25, 95% CI 1.22-4.18, p=0.006 and OR 1.70, 95% CI
1.13-2.57, p =0.012). In a separate analysis that controlled confounding variables such as
presence of preeclampsia and gestational diabetes, maternal education, induction of labor,
and birth centile pregnancy onset snoring was independently associated with emergency
cesarean delivery (OR 1.68, 95% CI 1.22-2.30, p=0.001).
With more operative deliveries and more emergent operative deliveries a rise in
morbidity can be expected but the underlying cause needs to be evaluated, especially if it
is preventable. Emergent operative deliveries and intensive care for infants of low birth
weight or small-for-gestational-age is extremely expensive. A wide range of
complications from surgery may occur and can range from the mundane to life
threatening. If a facility is unprepared or lacks adequate resources to manage a maternal
or neonatal complication related to SDB the result may be catastrophic.
During labor and delivery, OSA also has been linked with outcomes that have
specific anesthesia implications. A study evaluating sleep in the five nights prior to
delivery and early labor found women with less total sleep time (TST) the night before
birth had higher total pain scores during labor (Beebe & Lee, 2007). Sleep deprivation
may impact the ability to tolerate labor pain and could change the timing and duration of
epidural pain management
Another unique study of OSA and pregnancy outcome is from Lee and Gay
(2004). A prospective observational study of 131 women during the ninth month of
pregnancy used actigraphy and questionnaires to determine the effect of sleep and fatigue
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on labor duration and delivery type. Participants wore a wrist actigraph to determine total
sleep time (TST) and wake after sleep onset (WASO)–an estimate of sleep disruption.
Women with sleep disruption (WASO ≥ 15%) were 5.2 times more likely to have
cesarean delivery. Women with a total sleep average of less than 6 hours of sleep per
night were 4.5 times more likely to have a cesarean delivery than women who averaged 7
hours of sleep. Labor duration was also studied but relied on self-report of labor duration
rather than confirmation by vaginal exam. This study proposes a prescription for an
amount of sleep (at least 8 hours) during pregnancy and draws on the analogy of other
habits during pregnancy. In addition to “eating for two” pregnant women should also
consider “sleeping for two” and should be getting a minimum of 8 hours of sleep each
night.
One of the most dramatic outcomes in the association between OSA and maternal
mortality comes from Louis et al. (2014). In a study using an estimated 55 million
records from the National Inpatient Sample over an 11-year period, women with OSA
had a approximately five-fold higher odds of dying prior to discharge than women
without OSA even after adjusting for comorbidities such as cardiovascular, renal, and
metabolic conditions (J. M. Louis et al., 2014). A risk this great demands action.
Obesity
Obesity is perhaps the strongest correlate with OSA across all populations. Excess
body weight and fat accumulation can work in several ways to develop OSA. Fat
accumulation can alter upper airway structure, increase total body oxygen demand, and
decrease functional residual capacity–all of which can promote or exacerbate OSA
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(Young et al., 2002). Excess weight gain before or during pregnancy in excess of Institute
of Medicine recommendations is also an independent predictor of preeclampsia.
Obesity is a significant confounding variable in the study of OSA. Excess weight
gain is thought to play a role in the development and progression of OSA. The overall
trend in the United States is an increase in the number of individuals who can be
classified as overweight or obese. A recent study found the incidence of obesity (BMI >
30) among adult women over 20 years of age in the U.S. is 35.8% (95% CI, 34.0-37.7%)
(Flegal, Carroll, Kit, & Ogden, 2012). When overweight (BMI > 25%) is included the
number jumps to 63.7% (95% CI, 60.9%-66.4%) (Flegal et al., 2012). Being overweight
during pregnancy increases the risk for several co-morbidities that have specific
cardiovascular implications for the nurse anesthetist. A large study in Denmark found
that as BMI increased above 25% the risk of co-morbid conditions and complications
increased. Notably, of all births in Denmark from January 1, 2004 through June 30, 2010,
Ovesen et al. (2011) found as BMI increased from overweight, obese, and severely obese
the odds ratios for diabetes, preeclampsia, and cesarean delivery also increased
significantly. Specifically for preeclampsia, the odds ratios were 1.9, 3, and 4.4 for the
three BMI groups. Because of the relationship between obesity and OSA, studies have
focused on the obese pregnant population. Louis et al. (2012) investigated outcomes of
175 obese gravid women and found OSA prevalence of 15.4% that was confirmed
through PSG. The authors noted the group diagnosed with OSA had a higher mean BMI
(46.8 ± 12.2 compared with 38.1 ± 7.5; p =.002), was more likely to be diagnosed with
asthma (48.1% compared to 22.9%, p =.007), and chronic hypertension (55.6% compared
to 32.4%; p=.02) than the control group.

21

Hypertension
The link between SDB and hypertensive disorders during pregnancy is becoming
more evident. O’Brien et al. (2012) conducted a prospective cohort study for pregnancyonset habitual snoring, gestational hypertension, and preeclampsia. Women were
recruited during their third trimester of pregnancy and compared to a non-pregnant
control group. This study chose to examine the presence of habitual snoring instead of
using a multi-item sleep disordered breathing questionnaire. The authors argue no study
has failed to associate snoring with objective measures of SDB obtained from
polysomnography and validation of SDB screening tools have not been performed on
pregnant subjects. The study reports pregnant women were more than twice as likely to
snore than the non-pregnant control group (34.1% vs. 14.9%, p < .0001). Through a
logistic regression that controlled for covariates, pregnancy-onset snoring was
independently associated with gestational hypertension (OR, 2.36; 95% CI, 1.48-3.77; p
< .001) and preeclampsia (OR, 1.59; 95% CI, 1.06-2.37; p = .024). This study is
important as the first to prospectively, in a large population, report significant risk to
maternal cardiovascular health from pregnancy-onset snoring.
These studies have focused on a sub-set of the obstetric population deemed to be
at high-risk for SDB and have not included the general obstetric population. While
obesity, diabetes, and hypertension have strong correlations with SDB, they have not
been shown as causative and it is possible to have SDB without any of these comorbidities. The prevalence of SDB in the general obstetric population is unknown.
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Screening
The Berlin questionnaire is widely used to screen for SDB/OSA and was
originally validated in the primary care setting, but has since been used in the surgical
population with moderately high sensitivity (68.9), specificity (56.4), positive predictive
value (77.9) and negative predictive value (44.9) (Chung & Elsaid, 2009). The Berlin
questionnaire consists of 11 items comprising three categories: snoring, daytime
sleepiness, and hypertension. The scoring of the instrument is cumbersome. Items have
multiple responses and are assigned a point value which is added with other items in the
category to create a category score that will either be “positive” or “negative.” If two of
the three categories are positive, the participant is at high risk for OSA. Reports of
sensitivity for the Berlin Questionnaire range from 54% to 86% with specificity from
43% to 87% in a primary care setting. In the surgical population, the Berlin Questionnaire
has been compared alongside the STOP Questionnaire and the American Society of
Anesthesiologists (ASA) checklist. The sensitivity and specificity of the Berlin
questionnaire varies depending upon the level of the apnea-hypopnea index (AHI) used
and the population under study. In addition, the Berlin questionnaire has been used in
pregnant populations (Sahin et al., 2008).
STOP-Bang (SB) is a model derived from the Berlin questionnaire and used
extensively in anesthesia. Initially, SB was created as a condensed, four item version of
the Berlin questionnaire for the surgical population that was easier to administer and
score (Chung et al., 2008a). SB was later created to gain greater sensitivity and
specificity. STOP-Bang consists of eight items: S-snoring, T-tired or fatigued, Oobserved apnea, P-pressure (high blood pressure), B-body mass index (BMI),
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A-age, N-neck circumference, and G-gender. STOP-Bang has a sensitivity of 83.6%,
92.9%, and 100% for the AHI cutoff scores of 5, 15, and 30 respectively. The test re-test
reliability was found to be 96.4% with a kappa coefficient of 0.923 (CI, 0.82-1.00). For
validity, the STOP questionnaire was compared against a one-night-in-laboratory PSG
study with a calculated apnea-hypopnea index (AHI) scored by a sleep physician using
American Academy of Sleep Medicine practice guidelines. The guidelines classify
severity as: mild (AHI 5-14), moderate (AHI 15-29), severe (AHI >30). Both STOP and
STOP-Bang models were assessed for sensitivity at the guideline levels. STOP has
sensitivities of 65.6% for AHI > 5, 74.3% for AHI > 15, and 79.5% for AHI > 30. The
alternative scoring model STOP-Bang had significantly increased sensitivities of 83.6 %
AHI ≥ 5, 92.9 % for AHI ≥ 15, and 100 % for AHI ≥ 30. Each item is a forced choice
yes/no question with basic measurements and simple calculations and can easily be
scored. Answering “yes” to three or more items indicates a high risk for OSA, answering
“yes” to less than three items is a low risk for OSA. The instrument can be completed in a
relatively short period of time and provides a simple endpoint of risk assessment for
OSA. Tantrakul et al (2015) recently validated the STOP-Bang in an obstetric population.
(Tantrakul et al., 2015) Pregnant women from a high-risk pregnancy clinic were recruited
to undergo sleep evaluations utilizing the Berlin and STOP-Bang questionnaires and athome overnight sleep studies. Of the 72 women recruited, 23 were in the first trimester,
24 in the second trimester, and 25 were in the third trimester. The prevalence of OSA by
trimester was 30.4% in the first, 33.33% in the second, and 32.0% in the third trimester
and was confirmed by sleep study. The sensitivity across the trimesters was 57.1% in the
first, 62.5% in the second, and 62.5% for the third. The specificity was 87.5% for the
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first, 93.8% for the second, and 88.2% for the third trimester. These values indicate a
limited utility for STOP-Bang in the first trimester but acceptable results for use in the
second and third trimester.
A Four-Variable Model (FFV) has been proposed specifically for use in the
pregnant population. Facco et al. (2012) set out to develop a screening algorithm using
the most sensitive indicators from the Berlin and ESS questionnaires by conducting a
multivariable logistic regression. While both Berlin and ESS performed poorly, four
variables overall were found to be independent significant factors in the identification of
OSA in high-risk pregnant women: self-reported snoring, chronic hypertension, prepregnancy BMI, and age. To score this assessment, the age is added to the BMI and if
snoring ≥3 times per week is noted, 15 points are added. If chronic hypertension is noted,
another 15 points is added. A combined score for all four variables ≥75 indicates SDB
with a sensitivity of 86% (95% CI, 66%, 95%) and a specificity of 74% (95% CI, 62%,
83%) while being validated in the pregnant population (Facco, Ouyang, Zee, & Grobman,
2012). This study points out while pregnant, daytime sleepiness is not specific to OSA
but is quite common throughout pregnancy. Neither ESS or Berlin includes age in the
assessment and the Berlin uses BMI ≥ 30 as a categorical variable where there may be a
more direct and linear relationship between OSA and BMI.
Anesthesia, OSA, and Pregnancy
Unlike the obstetrician who may have the benefit of establishing a relationship
and monitoring co-morbidities over the duration of the pregnancy, the anesthetist may
only meet the patient a few hours before delivery. Obstructive sleep apnea is associated
with obesity, preeclampsia, diabetes, difficult intubation, cesarean delivery, and
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sensitivity to anesthetic agents, sedatives and hypnotics–all of which can complicate
anesthetic care. In the immediate setting of providing anesthesia for a cesarean section,
perhaps the only modifiable risk factor is the anesthetic and the use of neuraxial narotics.
Preservative-free morphine has been approved for neuraxial administration for
post-operative analgesia since 1984 and has been used extensively (Sultan, Gutierrez, &
Carvalho, 2011). There is the potential adverse effect of respiratory depression that is
significantly concerning. The pharmacokinetics of opioids can be complex, especially
when comparing interactions or differences between compartments such as spinal or
epidural and plasma. Epidural pharmacokinetics are especially challenging as they may
vary by level of insertion (Sultan et al., 2011). The incidence of respiratory depression
from neuraxal administration of preservative-free morphine is difficult to ascertain. Kato
et al. (2008) conducted a retrospective review of 1,915 cesarean section cases that used a
standard dose of 0.15 mg intrathecal morphine. Of the study population, only five women
(0.26%) developed bradypnea (respiratory rate ≤ 10 breaths/min) and only one required
naloxone (0.052%). The study has key limitations that prevent application to broader
populations. The authors did not report a mean BMI for the study population and only
patient number five of the bradypnea group was reported to have an elevated BMI of 34.7
kg/m2. The study took place in Japan which may have a different rate of obesity than the
United States. A confounding variable, additional pain medication use during the study
period, was not reported and there was no investigation of sleep apnea or other comorbidities. A more relevant study to the US population that does account for obesity
was recently conducted. Crowgey et al. (2013) used a retrospective study of 5,036
postcesarean patients with a mean BMI = 34 kg/m2 who all received neuraxial morphine.
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The rate of obesity is impressive with 63% having a BMI ≥ 30 kg/m2. The anesthetic
dose and route were monitored with 3,554 patients receiving spinal morphine doses
ranging from 0.05 to 0.25 mg (90.4 % received 0.15 mg) and 1,080 patients receiving
epidural doses ranging from 1 to 5 mg (92.9% received 3 mg). The records were
reviewed to determine if naloxone was given to reverse respiratory depression or if the
Rapid Response Team (RRT) was activated to respond to the respiratory depression.
Despite the large sample size and prevalence of obesity, not a single patient was
identified as requiring naloxone treatment or rapid response team involvement for
respiratory depression. A significant limitation is the study does not account for minor
incidents of hypoventilation or desaturation primarily because respiratory monitoring was
intermittent. In addition, there was no investigation into co-morbid factors such as sleep
apnea. Both of these studies show a lack of respiratory depression in what should be an
at-risk population–especially with a high rate of obesity.
Screening for OSA may provide additional information to the nurse anesthetist
that might be used to alter the anesthetic plan. A provider may make extra preparations to
prepare for a difficult airway knowing there is a high likelihood for OSA. Epidural pain
management may be initiated earlier or a tenuous epidural replaced based on the
knowledge of an increased cesarean delivery rate with OSA. Narcotic dosing with spinal
anesthetics may be decreased or eliminated based on concerns for increased OSA after
surgery and a need for additional monitoring. Alternative pain management plans such as
non-narcotic pain medications and regional anesthesia such as transverse abdominal
plane blocks may be used. If general anesthesia is required, knowledge of OSA can affect
decisions about when to extubate. Resources for both mother and child may not be
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sufficient and a transfer of care may be required to a facility with a neonatal intensive
care unit (NICU) and continuous monitoring capability. Not knowing about a condition
like OSA that interacts with so many crucial aspects of anesthesia may be the most
dangerous situation of all.
Future Research
Many screening tools currently in use have been designed for sleep clinics or
primary care settings and may measure single attributes of SDB, such as sleepiness, but
not be of predictive value for SDB. Research shows pregnant women are at significant
risk of poor outcomes with tremendous cost to the patients and the healthcare system.
Sleep clinics and labs are already struggling to accommodate the increased awareness of
OSA in the general population and struggling to meet the need for screening. Pregnant
patients may choose not participate in overnight, in-lab PSG studies. Pregnancy,
especially late into the third trimester, is notorious for poor sleep even in the routine
conditions of home. Reporting to a hospital for an overnight study may be inconvenient
in accommodations have to be made for the care of children at home. While the risk of
respiratory depression after neuraxial narcotics may be low, the consequence may be
fatal. A nurse anesthetist in the busy perioperative setting can not change many of the risk
factors and co-morbid conditions but must adapt an anesthetic plan that best fits the
patient’s condition. Not knowing about the presence and severity of a condition like SDB
is a significant risk. Awareness of the prevalence of SDB at the time of delivery can help
in the allocation of resources and staffing. A screen that is simple, reliable, and valid for
the pregnant population could greatly improve the outcomes of a growing number of
obese pregnancies and enhance our understanding of SDB.
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CHAPTER III
METHODOLOGY
The purpose of this study was to examine the prevalence of Sleep Disordered
Breathing (SDB) and its association with perinatal complications in pregnant women at
delivery using the Facco Four Variable model and the STOP-Bang score at a large
Military Treatment Facility (MTF). In this chapter information on how the study was
conducted is provided and includes the study aims, the research design, the sample and
sampling, data collection procedures, and analysis plan. A discussion of protection of
human subjects is also provided.
Specific Aims:
Aim I.

To examine the prevalence of SDB using a cut-score of ≥75 on the Facco
Four Variable model and a score ≥ 3 on the STOP-Bang model in a general
obstetric population admitted in the immediate postpartum period at a large
academic Military Treatment Facility.

Aim 2:

To examine if parturients suspected of having SDB as assessed by the
Facco Four Variable Model (FFV; score ≥75) or the STOP-Bang (SB;
score ≥ 3) have higher rates of the following adverse maternal child
outcomes: gestational hypertension, low birth weight <2500 gms, NICU
admission, Preterm delivery <37 weeks gestation, preeclampsia/eclampsia,
gestational diabetes, cesarean delivery, hospital stay >5 days, a composite
score of adverse pregnancy outcomes, and a composite score of
cardiopulmonary complications that includes pulmonary embolism, in-
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hospital mortality, pulmonary edema, congestive heart failure, and
cardiomyopathy.
Aim 3.

Compare the prevalence rates of suspected SDB at delivery between active
duty and non-active duty parturients.

Design
This study used a prospective, cross-sectional, observational design utilizing the
Facco Four Variable (FFV) model and STOP-Bang model to examine the prevalence of
SDB in the third trimester, pregnant population at a large military treatment facility.
Sample and Sampling
The setting for this research was the post-partum wards of a tertiary care military medical
center and teaching hospital in the southwestern United States. The primary source for
data collection was from the main postpartum wards. The MTF averages more than 300
deliveries a month including high-risk and complicated OB patients. There is a dedicated
in-house obstetric anesthesia team supporting 10 labor, delivery, recovery, postpartum
(LDRP) suites 24 hours a day. Participants enrolled were geographically limited to
Southern California and the greater San Diego area.
Sample Size Estimation
The primary aim of this study was to examine the prevalence of SDB using a cutscore of ≥75 on the Facco Four Variable model and a score ≥ 3 on the STOP-Bang model
in a general obstetrical population in the immediate postpartum period at a large
academic Military Treatment Facility. Previous research suggest between 16.4 - 26.7% of
parturients considered to be at high-risk for SDB at term have symptoms and/or
confirmed SDB (Facco et al., 2012 and Pien et al., 2014). We estimated 20% of our
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patients may have symptoms of SDB at term. To estimate the sample size for a
descriptive study of a dichotomous variable, a sample size estimating table from Hulley
et al. (2007) was used. The expected proportion of our sample to screen positive for SDB
was 20%. With an estimated proportion of 0.20 positive for SDB, a 95% confidence
interval with a total width of 0.10 (0.05 below and 0.05 above), using table 6E our
estimated sample size was 246 participants. To account for attrition a total sample of 300
participants were recruited. The population at the site of the study was unique in that
active duty military and dependents all have access to the same high-quality health care.
None of the participants were uninsured or lacking resources for health care.
Additionally, the active duty subjects are required to maintain strict standards for body
composition and exercise performance. In theory, the active duty participants were in
good health. These two components made it difficult to estimate a prevalence of SDB and
adverse pregnancy outcomes for the study.
For the second aim, to examine if parturients suspected of having SDB as
assessed by the Facco Four Variable Model (score ≥75) and STOP-Bang (score ≥ 3) have
higher rates of the adverse pregnancy outcomes (gestational hypertension,
preeclampsia/eclampsia, gestational diabetes, non-elective cesarean delivery, NICU
admission, low birth weight <2500 gms, preterm delivery <37 weeks, a composite score
of adverse pregnancy outcomes, and a composite score of cardiopulmonary
complications (pulmonary embolism, in-hospital mortality, hospital stay >5 days,
pulmonary edema, congestive heart failure, cardiomyopathy). An analysis was conducted
after enrolling the first 300 participants. As previously stated, disparity between initial
prevalence estimates of outcome data resulted in a reassessment of sample size and study
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feasibility. Based on concerns for time, resources, and feasibility recruitment was halted
after an analysis of the initial 300 participants was concluded.
Data Collection Procedures
Patients in the third trimester of pregnancy were asked if they would like to
participate in the study “Sleep Disordered Breathing in Pregnancy.” The PI approached
the patient about her potential enrollment in the study if she was in the third trimester of
pregnancy and met the inclusion criteria with no conditions from the exclusion criteria.
Inclusion criterion: any woman eligible for care at MTF presenting for delivery in the
third trimester. Exclusion criteria were limited to any patient not wishing to participate in
the study, not eligible for care at MTF, not admitted for delivery, and any patient
admitted for fetal demise. The patient could refuse to participate at any time and
withdraw from the study without any retribution. Written informed consent was obtained,
baseline demographic data collected, and the Facco Four Variable and STOP-Bang
models were completed. This concluded Phase I of data collection. The participant was
told she could refuse to participate at any time and withdraw from the study at any time
without any retribution. The second phase of data collection commenced after the
participant completed the baseline study data. The electronic medical record was
reviewed after birth and data regarding the study outcome variables collected and entered
into the study database. This concluded the second phase of data collection.
Instrumentation
Facco Four Variable (FFV) Model. The gold standard for evaluating and
diagnosing OSA is an in-laboratory, overnight polysomnogram. Unfortunately, this test is
cumbersome, expensive, and time consuming. Alternative methods for screening and
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evaluating for obstructive sleep apnea have been developed, but very few have been
studied in the pregnant population. The Berlin questionnaire (Netzer et al., 1999) and the
Epworth Sleepiness Scale (ESS) (Johns, 1991) are instruments used to screen for sleep
disordered breathing and have both been tested in pregnant populations. The Berlin
questionnaire and the ESS were used to develop a four variable, pregnancy specific, SDB
screening model used in this study.
The Berlin questionnaire (Netzer et al., 1999) is perhaps the most widely used
screener for OSA and was originally validated in the primary care setting, but has since
been used in the surgical population with moderately high sensitivity (68.9), specificity
(56.4), positive predictive value (77.9), and negative predictive value (44.9).19 The
Berlin questionnaire consists of 11 items comprising three categories: snoring, daytime
sleepiness, and hypertension. The scoring of the instrument is cumbersome. Items have
multiple responses and are assigned a point value which is added with other items in the
category to create a category score that will either be “positive” or “negative.” If two of
the three categories are positive, the participant is at high risk for OSA. Reports of
sensitivity for the Berlin questionnaire range from 54% to 86% with specificity from 43%
to 87% in a primary care setting. The sensitivity and specificity of the Berlin
questionnaire varies depending upon the level of the apnea-hypopnea index (AHI) used
and the population under study. The Berlin questionnaire has been used in pregnant
populations. (Sahin et al., 2008)
From the Berlin questionnaire and the ESS, Facco and colleagues (2012)
developed a four variable model to screen for SDB during pregnancy. The Berlin and
ESS questionnaires were administered to 114 parturients at high-risk for SDB. The study
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participants also underwent an at-home overnight sleep study. An item analysis was
conducted to determine which items from each questionnaire were of greatest value in
accurately identifying a woman as having SDB. Demographic, clinical, and subjective
symptoms associated with SDB through univariable analysis were included as covariates
in a multivariable logistic regression model with the items from the Berlin and ESS
questionnaires. The result of the analysis is the four variable model: pre-pregnancy BMI,
age, chronic hypertension, and frequent snoring were independent significant risk factors
for SDB. The model consists of a score for these four variables to calculate a total score.
The subject receives 15 points for frequent snoring (≥ 3 times per week) and another 15
points if they report chronic hypertension. This sum is added to the summation of their
age (years) and BMI. If the total score is ≥75, the model predicts, in a high-risk group,
the diagnosis of OSA with a sensitivity of 85.7% (66.4%, 95.3%) and specificity of
73.6% (61.7%, 83.0%) (Facco et al., 2012).
STOP-Bang (SB) Model
STOP-Bang is a model also derived from the Berlin questionnaire. STOP-Bang
consists of eight items: S-snoring, T-tired or fatigued, O-observed apnea, P-pressure
(high blood pressure), B-body mass index >35 (BMI), A-age, N-neck circumference >40
cm, G-gender (Chung et al., 2008b). SB has a sensitivity of 83.6%, 92.9% and 100% for
the AHI cutoff scores of 5, 15, and 30 respectively. The test re-test reliability was found
to be 96.4% with a kappa coefficient of 0.923 (CI, 0.82-1.00). For validity, the STOP
questionnaire was compared against a one-night-in-laboratory PSG study with a
calculated apnea-hypopnea index (AHI) scored by a sleep physician using American
Academy of Sleep Medicine practice guidelines. The guidelines classify AHI severity as:
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mild AHI 5-15, 15-30 moderate, greater than 30, severe. STOP-Bang model was assessed
at the guideline levels with sensitivities of 83.6 % AHI > 5, 92.9 % for AHI > 15, and
100 % for AHI > 30. Each item is a forced choice yes/no question with basic
measurements, simple calculations, and easy scoring. Answering “yes” to three or more
items indicates a high risk for OSA, answering “yes” to less than three items is a low risk
for OSA. The instrument can be completed in a relatively short period of time and
provides a simple endpoint of risk assessment for OSA. STOP-Bang was developed for
use in sleep clinics, but has been evaluated during pregnancy. A recent study compared
SB with the Berlin questionnaire in each trimester of pregnancy in women recruited from
a high-risk antenatal clinic in Thailand (Tantrakul et al., 2015). A total of 72 women (23
first trimester, 24 second trimester, 25 third trimester) were recruited, completed both the
Berlin and SB questionnaires, and then given an at-home, wrist worn, overnight sleep
study. The authors used a unique cutoff point of BMI >27.5 for SB that was determined
to be culturally specific for their sample. The study found the ability of SB to recognize
OSA was poor in the first trimester (sensitivity = 57.1%, specificity = 87.5%, PPV =
66.7%, NPV = 82.7%, AUC 0.71, p = 0.23, CI 95% = 0.47-0.92), improved in the second
trimester (sensitivity = 62.5%, specificity = 93.8%, PPV = 83.3%, NPV = 83.3%, AUC
0.78, p = 0.23, CI 95% = 0.47-0.92), then decreased in the third trimester (sensitivity =
62.5%, specificity = 88.2%, PPV = 71.4%, NPV = 83.3%, AUC 0.75, p = 0.04, CI 95% =
0.53-0.97).
Outcome Data
Maternal Outcome data for this study was based on a review of the literature
and comes from studies that have focused on women at high risk for developing SDB
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(obesity, diabetes, hypertensive disorders). Obesity figures prominently in SDB and
multiple measures of body weight and body mass index was assessed. Due to the
association of SDB with hypertensive disorders in the general population, diagnosis of
hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, chronic
hypertension) were recorded from the electronic medical record along with any incidence
of pulmonary edema, congestive heart failure, or cardiomyopathy as a composite
variable of cardiopulmonary complications. Cesarean delivery has been associated
with obesity in the literature therefore SDB therefore delivery method (vaginal vs.
cesarean) was collected.
Infant Outcome data included low birth weight (<2500 gms), NICU admission, and
gestational age.
Statistical Analysis Plan
Aim 1: To examine the prevalence of SDB at time of delivery using the Facco Four
Variable Model and the STOP-Bang model in a general, third trimester, obstetric
population who deliver at a large Military Treatment Facility (MTF).
Aim 1 Analysis Plan: To examine the prevalence of SDB, a sample of 300 patients was
collected. Descriptive statistics were used to calculate the frequency and prevalence of
SDB as indicated by a score ≥75 on the Facco Four Variable model and a STOP-Bang
score ≥ 3. Percentages and frequencies were used to describe the results.
Aim 2:

To examine if parturients suspected of having SDB as assessed by the
Facco Four Variable Model (FFV; score ≥75) or the STOP-Bang (SB;
score ≥ 3) have higher rates of the following adverse maternal child
outcomes: gestational hypertension, low birth weight <2500 gms, NICU
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admission, Preterm delivery <37 weeks gestation, preeclampsia/eclampsia,
gestational diabetes, cesarean delivery, hospital stay >5 days, a composite
score of adverse pregnancy outcomes, and a composite score of
cardiopulmonary complications that includes pulmonary embolism, inhospital mortality, pulmonary edema, congestive heart failure, and
cardiomyopathy.
Aim 2 Analysis Plan: The outcome variables (gestational hypertension, low birth weight,
preeclampsia, gestational diabetes, cesarean delivery, hospital stay > 5 days, and a
composite variable of adverse pregnancy outcomes) and the diagnosis of SDB based on a
score ≥75 on the Facco Four Variable Model and a score of ≥ 3 for the STOP-Bang
model were dichotomized. Continuous variables such as age, weight (prepregnancy and
at delivery), BMI (prepregnancy and at delivery), neck circumference, gestational age,
and length of stay were assessed by t-test. Fisher’s Exact test was used for dichotomous
variables such as prepregnancy BMI >30, primigravid status, pregestational diabetes,
previous cesarean delivery, prior preeclampsia, NICU admission, preterm delivery <37
weeks, low birth weight <2500 gms, and chronic hypertension. Next, logistic regression
was used to examine the risk of adverse pregnancy outcomes (gestational hypertension,
preeclampsia/eclampsia, gestational diabetes, cesarean delivery, NICU admission, low
birth weight <2500 gms, preterm delivery <37 weeks, a composite of adverse pregnancy
outcomes, and a composite score of cardiopulmonary complications (pulmonary
embolism, in-hospital mortality, hospital stay >5 days, pulmonary edema, congestive
heart failure, cardiomyopathy) in patients with and without SDB. Within our model we
adjusted for several maternal characteristics and other covariates (active duty status,
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ethnicity, obesity, advanced maternal age, parity, twin gestation). Adjusted and
unadjusted odds ratios (OR) with the 95% confidence interval were calculated. A p-value
< 0.05 was considered significant.
Aim 3-Exploratory: Compare the prevalence rates of suspected SDB at delivery between
active duty and non-active duty parturients.
Aim 3 Analysis Plan: Descriptive statistics were used to calculate the frequency and
prevalence of SDB as indicated by a score ≥75 on the Facco Four Variable model and a
score of ≥ 3 for the STOP-Bang model in each group. Bivariate descriptive statistics were
computed to compare active-duty vs. dependent patients with the presence or absence of
SDB as determined by each instrument. Percentages and odds ratios with 95% confidence
intervals (95% CI) were used to describe the results.
Compliance Plan
The principal investigator was present in the post-partum wards for the
recruitment of all participants.
Statement of Assumptions and Protection of Human Subjects
Previous studies have been conducted using similar methods without report of
harm to the subject. Completion of a questionnaire involves minimal risk to a subject
who is no greater than risk experienced in everyday life.
Fatigue may pose a minimal risk to the subjects while completing the
demographic data and questionnaire. Subjects were seated while the PI gathered the data
and the entire process took less than 30 minutes to complete. If fatigue occurred, subjects
could terminate the session and dis-enroll from the study.
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The Principal Investigator is a Naval Officer and Certified Registered Nurse
Anesthetist (CRNA) and subjects may be enlisted military members, officers of lower or
higher rank, or have preferences about the use of anesthesia for delivery. The risk of
coercion or intimidation was addressed by the PI not wearing a military uniform. The
subjects were vocally instructed their participation was completely voluntary and they
could dis-enroll at any time without any bearing on the healthcare they receive or their
military service.
Confidentiality was maintained through the use of a unique subject identifier
linked to all gathered data and only the investigators have access to this link. All
electronic data is stored on a password-protected computer and the computer stored in a
locked case. All of these measures ensure compliance with HIPAA standards.
Safety Precautions and Emergency Protocols
The study involved minimal risk to the subjects and did not interfere with care
being rendered for the pregnancy. The interviews were conducted on the hospital grounds
and standard Navy medical procedure and hospital policy was deemed sufficient for
immediate management of medical events or injuries.
Description of the system for Maintenance of Records
The sources of data for this study are the demographic information file and case
report form containing the Facco Four Variable model and STOP-Bang model. All of the
instruments were coded with the subject identification number. A master coding list was
kept in a locked file in an assigned office at MFT, accessible only to the investigators.
No protected health information was on any of the data collection forms or computer
files. The principal investigator kept the research protocols and consent forms in a locked
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file in an assigned office at NMCSD in compliance with SECNAVINST 3900.39C and
BUMEDINST 3900.6B.
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CHAPTER IV
RESULTS
The purpose of this study was to examine the prevalence of Sleep Disordered
Breathing (SDB) and its association with perinatal complications in pregnant women at
delivery using the Facco Four Variable model and the STOP-Bang score at a large
Military Treatment Facility (MTF). In this chapter, study results will be presented
including sample characteristics and results for each research aim.
Data were collected from March 24, 2015 through June 17, 2015 on 37 data
collection days. A total of 320 eligible women were screened on the postpartum wards at
a tertiary care Military Treatment Facility (MTF) with 302 women (94%) agreeing to
participate and enroll in the study. A database was created using SPSS Statistical
Software version 23. After reviewing questionnaires and cleaning the data (excluded twin
deliveries), data provided by 295 participants were used for the analyses.
Participant Profile
Study participants were women eligible for care in the Department of Defense,
Military Health System and were categorized as either an active duty service member or
other. Active duty participants comprised 38.5% (n=116) of the total sample. The active
duty group was 86.5 % Navy, 9% Marine Corps, 1.8% Air Force, and 1.8% Army.
Enlisted ranks from E2-E8 were represented with the largest portion being E4 with
25.7%, E5 24.8%, and E3 23.9%. Officer participants were considerably smaller in
number with only 11 participants (3.8%) whose rank ranged from O1-O4. The sample
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was diverse with 51.7% White, 16.2% Latina, 14.2% Black, and 17.9% Other included
Asian, Pacific Islander, Native Hawaiian, and Native American/Alaskan Native.
Participants mean age was 27.5 ± 5.27 years with a range of 17-43 years. For 37%
of the sample, this was their first delivery (primiparous) and mean gestation was 274 days
±10.03 (39 weeks, 1 day), range 230 days (32 weeks, 6 days) to 292 days (41 weeks, 5
days). The mean pre-pregnancy weight was 150.68 lbs (68.34 kg) ± 34.10, range 77 lbs.
(34.9 kg) to 284 lbs. (128.82 kg); a mean weight gain of 33.54 lbs ± 6.62(15.21 kg) range
a loss of 13 pounds (5.89 kg) to a maximum gain of 76 lbs. (34.47 kg). At delivery, the
mean weight was 184.42 lbs (83.65 kg) with a range of 105-299 lbs (47.62-135.62 kg).
For delivery BMI, the mean was 31.26 ±5.27with a range of 20.98-46.82. Neck
circumference measured at delivery had a mean of 13.98 in ± 2.69 (35.51 cm), range
10.63 in.-17.72 in (27-45 cm). The mean birth weight was 7 lbs 6 oz ± 534.07 (3351.52
gm), range 12.69 oz-10 lbs, 5.64 oz (360 gm-4899 gm). The mean length of stay was 3.57
days ± 1.02 with a range of 2-10 days. See Table 1.
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Table 1
Demographic and Clinical Characteristics of Study Population (N = 295)
Characteristic

n

%

M

SD

Range

Age (years)

--

--

27.47

5.30

17 - 43

156 51.7

--

--

--

Hispanic

49 16.2

--

--

--

Black

43 14.2

--

--

--

All Others

54 17.8

--

--

--

Active Duty

116 38.3

--

--

--

Dependent

184 61.1

--

--

--

Race
White

Military Status

Body Mass Index (kg/m2)
Pre-pregnancy

--

--

25.54

5.22

16 - 45

Delivery

--

--

31.26

5.27

21 - 47

Weight Gain During Pregnancy (kg)

--

--

15.19

6.62

-6 - 35

Gestational Age (days)

--

--

275.19

9.63

230 - 292

Neck Circumference (cm)

--

--

35.51

2.69

27 - 45

Child’s Birth Weight (g)

--

--

3355.00

534.07

360 - 4899

Length of Stay at Hospital (days)

--

--

3.56

1.02

2 - 10

Note. M = Mean; SD = Standard Deviation. Some percentages do not add up to 100 because of missing
data.
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Comorbidities found in the sample are presented in table 2. Induction of labor
was noted in 38.6% (n=115) of deliveries, 22.8% (n=69) had a cesarean delivery, and
6.3% (n=19) delivered prior to term. A pre-pregnancy BMI >30 was noted in 18.7%
(n=56). Gestational hypertension was found in 9.9% (n=30), preeclampsia in 9.3%
(n=28), and gestational diabetes in 6% (n=18). Of the infants, 7.3% (n=22) were
determined to have low birth weight <2500 grams and 10.9% (n=33) required admission
to the NICU.

Table 2
Overall Prevalence of Select Comorbidity (N = 295)
Sleep Disordered Breathing
Present

Absent

Comorbidity

N

%

n

%

Gestational Hypertension

30

9.9

265

90.1

Gestational Diabetes

18

6

289

94.0

Preeclampsia

28

9.3

267

90.7

Preterm Delivery (< 37 weeks)

19

6.3

276

93.7

Low Birth Weight (< 2500 g)

22

7.3

273

92.7

Induction

115

38.6

180

61.4

Cesarean Delivery

69

22.8

226

77.2

NICU Admission

33

10.9

262

89.1

Pre-pregnancy BMI (≥ 30 kg/m2)

56

18.7

239

81.3

Note. BMI = Body Mass Index; NICU = Neonatal Intensive Care Unit. Some percentages do not add up to
100 because of missing data.
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Specific Aim #1
To examine the prevalence of SDB at time of delivery using the Facco Four
Variable Model of SDB in pregnancy and the STOP-Bang score ≥3 in a general, third
trimester, obstetric population who deliver at a large Military Treatment Facility (MTF).
The prevalence of OSA in the sample was 12.3% (n=36) utilizing the Facco Four
Variable (FFV) model and 7.1% (n=21) utilizing the STOP-Bang model.
Specific Aim #2
To examine if parturients suspected of having SDB as assessed by the Facco Four
Variable Model (FFV; score ≥75) or the STOP-Bang score ≥ 3 have higher rates of the
following perinatal maternal-infant outcomes: gestational hypertension, low birth weight,
preeclampsia/eclampsia, gestational diabetes, cesarean delivery, hospital stay >5 days, a
composite score of adverse pregnancy outcomes, and a composite score of cardiovascular
complications that includes pulmonary embolism, in-hospital mortality, pulmonary
edema, congestive heart failure, and cardiomyopathy.
Parametric and nonparametric tests were used to examine differences in being
high-risk for SDB (FFV ≥75 or STOP-Bang ≥3) and demographic and clinical variables.
Chi-square and Fischers Exact tests were used to examine the association between being
high-risk for SDB and adverse pregnancy outcomes. Multivariable logistic regression
was used to examine if the FFV model (≥75) was predictive of a composite adverse
pregnancy outcomes variable while controlling for covariates. All potential covariate
variables (primagravida, prior cesarean delivery, prior preeclampsia, advanced maternal
age, chronic HTN, pregestational DM, obesity, and weight gain during pregnancy) were
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entered into the model, those variables with a p > .10 were eliminated from the final
model, p < .05 was significant.
Facco Four Variable Model (FFV) demographics. Using the FFV, 12.3% of
participants (n=36) screened positive with a score ≥ 75. Statistically significant
differences were found in women who screened positive for SDB versus those who did
not (Table 3). Women who screened positive on the FFV with a score ≥75 were found to
be older (32.9 ± 5 years vs. 26.7 ± 4.7, p <.0001), to have a pre pregnancy BMI >30
(61.1% vs. 12.8%, p <.0001), a higher delivery BMI (36.6± 5.1 vs 30.5±4.8, p <.0001), a
larger neck circumference (37.7 cm±2.3 vs. 35.2 ±2.6 p <.0001), more chronic
hypertension (19.4% vs. 1.6% p <.0001), and had a higher incidence of a previous
cesarean delivery (30.6% vs. 19.1% p <.0001).
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Table 3
Demographic and Clinical Characteristics by Facco Four Variable Model Categorical
(N = 295)
Facco (+) n=36
Facco (-) n=259

Variable

M

SD

M

SD

t

Age (years)

32.97

5.02

26.74

4.87

-7.16**

Pre-Pregnancy BMI (kg/m2)

31.96

6.38

24.64

4.34

-8.87**

Delivery BMI (kg/m2)

36.58

5.14

30.50

4.84

-7.00**

Gestational Age (days)

273.78

9.74

275.39

9.65

0.94

Neck Circumference (cm)

37.71

2.38

35.18

2.58

-5.91**

χ2

n

%

n

%

White

19

50.0

135

51.5

Hispanic

42

16.0

7

18.4

Black

6

15.8

37

14.1

All Others

6

15.8

48

18.3

7

19.4

101

39.3

5.35*

22

61.1

33

12.8

28.25**

Chronic Hypertension

7

19.4

4

1.6

27.84**

Prior Preeclampsia

4

11.1

10

3.9

3.56

Pregestational Diabetes

0

0.0

3

0.2

0.43

Prior Cesarean Delivery

32

30.6

11

12.5

8.12**

Stop-Bang (+)

23

63.9

49

19.1

34.23**

Race

Primigravida
Pre-pregnancy BMI ≥ 30

0.31

Note. BMI = Body Mass Index; M = Mean; SD = Standard Deviation. This table only presents n and %
values for the presence (coded “Yes” = 1) of Primigravida, Pre-Pregnancy BMI ≥ 30 (kg/m2), Chronic
Hypertension, Prior Preeclampsia, Pregestational Diabetes, Prior Cesarean Delivery, and Stop-Bang Score
≥ 3 (high-risk for Obstructive Sleep Apnea).

* p ≤ .05, ** p ≤ .001.
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Facco Four Variable Model (FFV) Chi-Square tests. Subjects who were
considered high-risk for SDB based on the FFV (FFV ≥75) were found to have
statistically significantly higher rates of adverse pregnancy outcomes (composite score =
58.3% vs. 39.7%, p = .027). Women who screened positive for SBD using the FFV
model had a statistically significant higher unadjusted rates of cesarean delivery (36.1%
vs. 20.6%, p = .035; (Figure 2). (Table 4). Higher rates of gestational hypertension
(16.7% vs. 9.3%, p = .14), gestational diabetes (8.3% vs. 5.1%, p = .31), and NICU
admission (11.1% vs. 9.7%, p = .49) were found in subjects with FFV ≥75), but
differences were not statistically significant. No patients experienced any
cardiopulmonary complications.
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40

*

Frequency %

35
30
25

Facco (+)

20
Facco (-)

15
10
5
0

Adverse Pregnancy Outcomes

Figure 2. Adverse Pregnancy Outcomes by Facco Four Variable Model Categorical
(N = 295). Facco (+) categorical score = Age (years) + Pre-pregnancy BMI (kg/m2) +
Snoring ≥ 3 days/week (15 points) + Pre-pregnancy Hypertension (15 points). Facco (+)
≥ 75 = positive screening for Sleep Disordered Breathing.
* p ≤ .05, ** p ≤ .001.
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Table 4
Adverse Pregnancy Outcomes by Facco Four Variable Model Categorical (N = 295)
Facco (+) n=36a

Facco (-) n=254

Variable

n

%

n

%

χ2

APO Composite Score b

21

58.3

103

40.1

4.31*

Gestational Hypertension

6

16.7

24

9.3

1.85

Gestational Diabetes

3

8.3

13

5.1

0.66

Preeclampsia

3

8.3

24

9.3

0.04

Preterm Delivery (< 37 weeks)

2

5.6

13

5.1

0.02

13

36.1

53

20.6

4.34*

Low Birth Weight (< 2500 g)

1

2.8

13

5.1

0.37

NICU Admission

4

11.1

25

9.7

0.07

1

2.8

12

4.7

0.53

Cesarean Delivery

Length of Stay at Hospital (> 5
days)
Note. APO = Adverse Pregnancy Outcomes; NICU = Neonatal Intensive Care Unit. This table only
presents n and % values for the presence (coded “Yes” = 1) of APO Composite Score, Gestational
Hypertension, Gestational Diabetes, Preeclampsia, Preterm Delivery (< 37 weeks), Cesarean Delivery, Low
Birth Weight (< 2500 g), NICU Admission, and Length of Stay at Hospital (> 5 days). Analysis excluded
cases of twin delivery.
a
Facco (+) = Age (years) + Pre-pregnancy BMI (kg/m2) + Snoring ≥ 3 days/week (15 points) + Prepregnancy Hypertension (15 points). Facco (+) ≥ 75 = positive screening for Sleep Disordered Breathing.
b
APO Composite Score = “Yes,” if all APOs above are present.

* p ≤ .05, ** p ≤ .001.
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Logistic regression of Facco Four Variable categorical score (FFV +). A test
of full model against a constant only model was statistically significant using the FFV as
a categorical variable, indicating predictors, as a set, reliably distinguished between those
who had an adverse pregnancy outcome (X 2 = 33.286, p<.0001, df = 5). HosmerLemeshow test indicated the model was a good fit to the data, X 2 =7.342 df(4), p =.119.
Nagelkerke’s R2 of .133 indicated a small relationship between prediction and grouping.
The model correctly classified 64.6% of cases. The Wald criterion demonstrated
primigravida, prior cesarean delivery (CSD), and prior preeclampsia made a significant
contribution to the probability of a patient having a adverse pregnancy outcome (p<.05).
The FFV (+) was not significantly associated with adverse pregnancy outcomes (B =.405,
Wald = .924, p = .336, OR = 1.499, 95% CI = .657-3.423). (Table 5).
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Table 5
Logistic Regression Analysis for Variables Predicting Adverse Pregnancy Outcomes
Utilizing the Facco Four Variable Model Categorical Score. (N = 295)
Adverse Pregnancy Outcomes
Predictor

B

SE B

OR

95% CI

Facco (+) a

0.595

.388

1.813

[0.85, 3.98]

Primigravida

0.672*

.273

1.958

[1.15, 3.35]

Prior Cesarean Delivery

1.253**

.381

3.499

[1.66, 7.38]

Prior Preeclampsia

2.182**

.794

8.864

[1.87,
42.00]
Constant

-0.934**

.197

0.393

χ2

28.89**

df

4

% APO

--

64.60

Note. Facco (+) = Facco Four Variable Model Categorical Score (≥ 75); APO = Adverse Pregnancy
Outcomes; OR = odds ratio; CI = confidence interval. The APO Composite Score variable includes the
following risk factors; Gestational Hypertension, Preeclampsia, Gestational Diabetes, Cesarean Delivery,
Low Birth Weight, NICU Admission, Preterm Delivery, and Hospital Stay (> 5 days). Analysis excluded
cases of twin delivery.
a
Facco (+) = Age (years) + Pre-pregnancy BMI (kg/m2) + Snoring ≥ 3 days/week (15 points) + Prepregnancy Hypertension (15 points). Facco (+) ≥ 75 = positive screening for Sleep Disordered Breathing.

* p ≤ .05, ** p ≤ .001.
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Logistic regression Facco Four Variable–Absolute Score. A test of full model
against a constant only model was statistically significant using the FFV as a continuous
variable using the total score, indicating that predictors, as a set, reliably distinguished
between those who had a adverse pregnancy outcome (X 2 = 32.678, p<.0001, df =4).
Hosmer-Lemeshow test indicated the model was a good fit to the data, X 2 =7.971 df(8),
p =.436. Nagelkerke’s R2 of .143 indicated a small relationship between prediction and
grouping. The model correctly classified 66.3% of cases. The Wald criterion
demonstrated FFV-AS, primagravida, prior cesarean delivery (CSD), and prior
preeclampsia made a significant contribution to the probability of a patient having a
adverse pregnancy outcome (p<.05). The FFV-AS was significantly associated with
adverse pregnancy outcomes (B =.028, Wald = 6.193,p = .013, OR = 1.028, 95% CI =
1.006-1.051). As the FFV-AS score increased, the odds of an adverse pregnancy outcome
increase by 1.028. (Table 6)
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Table 6
Logistic Regression Analysis for Variables Predicting Adverse Pregnancy Outcomes
Utilizing the Facco Four Variable Model Continuous Score. (N = 295)
Adverse Pregnancy Outcomes
Predictor

B

SE B

OR

95% CI

Facco Score a

0.028*

.011

1.028

[1.01, 1.05]

Primigravida

0.684*

.277

1.982

[1.15, 3.41]

Prior Cesarean Delivery

1.094**

.389

2.986

[1.39, 6.40]

Prior Preeclampsia

-2.212**

.795

9.137

[1.93,

Constant

-2.499**

.693

0.082

--

χ2

32.68**

df

4

% APO

66.30

Note. Facco Score = Facco Four Variable Model Continuous Score; APO = Adverse Pregnancy Outcomes;
OR = odds ratio; CI = confidence interval. The APO Composite Score variable includes the following risk
factors; Gestational Hypertension, Preeclampsia, Gestational Diabetes, Cesarean Delivery, Low Birth
Weight, NICU Admission, Preterm Delivery, and Hospital Stay (> 5 days). Analysis excluded cases of twin
delivery.
a

Facco Score = Age (years) + Pre-pregnancy BMI (kg/m2) + Snoring ≥ 3 days/week (15 points) + Prepregnancy Hypertension (15 points).

* p ≤ .05, ** p ≤ .001.

STOP-BANG demographics. Compared to the 36 women who screened positive
on the FFV, only 21 women screened positive on the STOP-Bang. Women who screened
positive for SDB with a STOP-BANG ≥3 score had some significant differences from
those that who did not. (Table 7), specifically weight and body mass index (BMI). Prepregnancy weight (190.3 ± 39.3 vs. 147.6 ± 32.0 t (292) = 5.795, p = <.001), pre-
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pregnancy BMI (31.7 ± 6.3 vs. 25.1 ± 4.8, p = <.0001), delivery weight (224.7 ± 24.7 vs.
181.0 ± 33.9, p = <.0001), and delivery BMI (37.6 ± 3.6 vs. 30.80 ± 5.1, p = <.0001), and
pre-pregnancy BMI >30% (61.9 vs.15.4, p = <.0001). More women with chronic
hypertension (14.3% vs. 2.9%, p = .036) screened positive, as well as those with a larger
neck circumference (39.5 cm vs. 35.2 cm, t(292) = 7.667, p <.0001). Prepregnancy BMI
>35, chronic hypertension, and age are all factors in the STOP-Bang model and greater
percentages among women that screened positive with the instrument can be expected. A
longer hospital stay was also noted among women who screened positive for SDB (4.0 ±
1.2 days vs. 3.5 ± 1.0 days, t(288)=2.091, p = .037.
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Table 7
Demographic and Clinical Characteristics by Stop-Bang Categorical (N = 295)
Stop-Bang (+)

Stop-Bang (-)

M

SD

M

Age (years)

29.48

6.02

27.32

5.22

-1.80

Pre-pregnancy BMI (kg/m2)

31.71

6.31

25.07

4.82

-5.95**

Delivery BMI (kg/m2)

37.55

3.58

30.77

5.06

-6.02**

Gestational Age (days)

273.62

11.36

275.31

9.50

0.78

39.48

2.49

35.21

2.46

-7.67**

n

%

n

%

White

8

38.1

148

52.7

Hispanic

4

19.0

45

16.0

Black

6

28.6

37

13.3

All Others

3

14.3

51

18.1

7

33.3

14

36.2

0.13

13

61.9

42

15.4

27.6**

Chronic Hypertension

3

14.3

8

2.9

6.98**

Prior Preeclampsia

1

4.8

13

4.8

0.00

Pregestational Diabetes

0

0.0

3

1.1

0.23

Prior Cesarean Delivery

4

19.0

39

14.3

0.35

Variable

Neck Circumference (cm)

SD

t

χ2

Race

Primigravida
Pre-pregnancy BMI ≥ 30

4.33

Note. BMI = Body Mass Index; M = Mean; SD = Standard Deviation. This table only presents n and %
values for the presence (coded “Yes” = 1) of Primigravida, Pre-Pregnancy BMI ≥ 30 (kg/m2), Chronic
Hypertension, Prior Preeclampsia, Pregestational Diabetes, Prior Cesarean Delivery, and Stop-Bang Score
(+) ≥ 3 (high-risk for Obstructive Sleep Apnea).
* p ≤ .05, ** p ≤ .001.
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STOP-BANG Chi-Square tests. Subjects who were considered high-risk for
SDB based on the STOP-Bang score ≥ 3 were found to have statistically significant
higher rates of several adverse pregnancy outcomes (table 8): composite score (66.7% vs.
40.9%, p = .019), gestational hypertension (33.3% vs. 8.4%, p = .002), and cesarean
delivery (42.9% vs. 21.2, p = .027). Higher rates of preeclampsia (19.0% vs. 8.4%, p =
.112) and low birth weight <2500 grams (9.5% vs. 4.8%, p = .293), and NICU admission
(19.0% vs. 9.5%, p = .152), were found, but did not reach statistical significance. Similar
rates of gestational diabetes (5.5% vs. 5.4%, p = .590), pre-term delivery less than 37
weeks (4.8% vs. 5.1%, p = .710), and length of stay greater than 5 days (0% vs. 2.3%)
were found in subjects with a STOP-Bang score ≥3. No participants experienced any
cardiopulmonary complications.
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Table 8
Adverse Pregnancy Outcomes by Stop-Bang Categorical (N = 295)
Stop-Bang (+) a

Stop-Bang (-)

Variable

n

%

n

%

χ2

APO Composite Score b

14

66.7

112

40.9

5.30*

Gestational Hypertension

7

33.3

23

8.4

13.28**

Gestational Diabetes

1

4.8

15

5.5

0.02

Preeclampsia

4

19.0

23

8.4

2.66

Preterm Delivery (< 37 weeks)

1

4.8

14

5.1

0.01

Cesarean Delivery

9

42.9

58

21.2

5.23*

Low Birth Weight (< 2500 g)

2

9.5

13

4.8

0.90

NICU Admission

4

9.5

26

19.0

1.95

3

14.3

10

3.6

5.55

Length of Stay at Hospital (> 5
days)
Note. APO = Adverse Pregnancy Outcomes; NICU = Neonatal Intensive Care Unit. This table only
presents n and % values for the presence (coded “Yes” = 1) of APO Composite Score, Gestational
Hypertension, Gestational Diabetes, Preeclampsia, Preterm Delivery (< 37 weeks), Cesarean Delivery, Low
Birth Weight (< 2500 g), NICU Admission, and Length of Stay at Hospital (> 5 days). Analysis excluded
cases of twin delivery.
a

Stop-Bang (+) continuous score was calculated. A Stop-Bang (+) ≥ 3 indicated high-risk for Obstructive
Sleep Apnea; a Stop-Bang (-) < 3 indicated low-risk for Obstructive Sleep Apnea.
b
APO Composite Score = “Yes,” if all APOs above are present.
* p ≤ .05, ** p ≤ .001.
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Logistic regression of STOP-BANG ≥3 = High Risk. A test of full model
against a constant only model was statistically significant, indicating that predictors, as a
set, reliably distinguished between those who had a adverse pregnancy outcome (X 2 =
31.806, p<.0001, df =4). (Table 9) Hosmer-Lemeshow test indicated the model was a
good fit to the data, X 2 =.088 df(2), p =.957. Nagelkerke’s R2 of .138 indicated a small
relationship between prediction and grouping. The model correctly classified 65.5% of
cases. The Wald criterion demonstrated SB High Risk, primagravida, prior cesarean
delivery (CSD), and prior preeclampsia made a significant contribution to the probability
of a patient having an adverse pregnancy outcome (p<.05). The SB High Risk was
significantly associated with adverse pregnancy outcomes (B =1.167, Wald = 5.503, p =
.019, OR = 3.211, 95% CI = 1.211-8.510). As the SB High Risk score increased, the odds
of an adverse pregnancy outcome increase by 3.21. (Figure 3).
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Table 9
Logistic Regression Analysis for Variables Predicting Adverse Pregnancy Outcomes
Utilizing the Stop-Bang Categorical Score. (N = 295)
Adverse Pregnancy Outcomes
Predictor

B

SE B

OR

95% CI

Stop-Bang (+) a

1.167

.497

3.211

[1.21, 8.51]

Primigravida

0.657

.273

1.928

[1.13, 3.29]

Prior Cesarean Delivery

1.314

.380

3.721

[1.77, 7.84]

Prior Preeclampsia

2.311

.796

10.081

[2.12, 47.98]

Constant

-0.932

.194

0.394

--

χ2

31.81**

df

4
65.50

% APO

Note. APO = Adverse Pregnancy Outcomes; OR = odds ratio; CI = confidence interval. The APO
Composite Score variable includes the following risk factors; Gestational Hypertension, Preeclampsia,
Gestational Diabetes, Cesarean Delivery, Low Birth Weight, NICU Admission, Preterm Delivery, and
Hospital Stay (> 5 days). Analysis excluded cases of twin delivery.
a

Stop-Bang (+) continuous score was calculated. A Stop-Bang (+) ≥ 3 indicated high-risk for Obstructive
Sleep Apnea; a Stop-Bang score (-) < 3 indicated low-risk for Obstructive Sleep Apnea.

* p ≤ .05, ** p ≤ .001.
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50
45

*

Frequency %

40
35

**

30

Stop-Bang (+)

25

Stop-Bang (-)

20
15
10
5
0

Adverse Pregnancy Outcomes
Figure 3. Adverse Pregnancy Outcomes by Stop-Bang (+) (N = 295). Stop-Bang (+) ≥ 3
indicated high-risk for Obstructive Sleep Apnea; a Stop-Bang (-) < 3 indicated low-risk
for Obstructive Sleep Apnea.
* p ≤ .05, ** p ≤ .001.
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Exploratory Aim. Compare demographic, outcomes data, and the prevalence
rates of suspected SDB at delivery between active duty (AD) and non-active duty or
dependent (DEP) parturients.
Exploratory aim demographics. Of 294 participants, 38.6% (n=114) were active
duty and 60.7% (n=179) were dependents (Table 10). An independent samples t-test was
conducted on demographic and outcomes data and statistically significant differences
were found between active duty and dependents in age and weight gained during
pregnancy. Active duty participants were younger (M=25.55, SD=4.68) compared to
dependents (M=28.71, SD=5.33), (t (291) = 5.179, p=.0001). Weight gain during
pregnancy was greater among active duty (M=38.50 lbs, SD=15.19) compared to
dependents (M=30.40 lbs, SD=13.54) t (285) =4.701, p=.0001. Active duty women were
more likely to be primigravid (47.4%versus30.7%) Pearson X 2=8.859, df(2), p=.012.
A significant association was noted between a positive FFV score and active duty
status, with active duty subjects having significantly lower rates of SDB as defined by the
FFV model (≥75; active duty: 16.7% (n=6) vs dependents: 83.3% (n=30) Pearson ChiSquare = 8.663, df(2), p=.013). When utilizing the STOP-Bang instrument 7.1% (n=21)
of participants screened positive for SDB. Of the 21 positive screenings, 42.9% (n=9)
were active duty compared to 57.1% (n=12) dependents.
For adverse pregnancy outcomes, 42.5% (n=125) of participants experienced an
adverse pregnancy outcome. There was no association between active duty or dependent
status and the rate of adverse pregnancy outcomes. Of the active duty participants, 39.5%
(n=45) had an adverse pregnancy outcome while 44.7 % (n=80) of dependents
experienced one (Pearson Chi-Square = 1.518 df(2), p=.468).
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Table 10
Demographic and Clinical Characteristics of Study Population by Military Status (N =
295)
Active Duty
Dependents

Variable

M

SD

M

SD

t

Age (years)

25.55

4.68

28.71

5.33

-5.18**

Pre-Pregnancy BMI (kg/m2)

25.12

3.76

25.82

5.98

-1.11

Delivery BMI (kg/m2)

31.62

4.51

31.07

5.71

0.87

Gestational Age (days)

276.08

9.70

274.57

9.60

1.31

35.55

2.54

35.50

2.80

0.16

χ2

Neck Circumference (cm)

n

%

n

%

White

55

47.4

100

54.3

Hispanic

18

15.5

30

16.3

Black

25

21.6

18

9.8

116

100.0

184

100.0

Primigravida

54

47.4

55

30.7

8.86*

Pre-pregnancy BMI ≥ 30

16

13.9

40

21.9

3.16

Chronic Hypertension

2

1.8

9

5.1

2.14

Prior Preeclampsia

4

3.5

10

5.6

0.75

Pregestational Diabetes

2

1.8

1

0.6

1.00

Prior Cesarean Delivery

9

7.9

33

18.6

6.68*

26

22.8

47

26.3

0.78

Race

All Others

Stop-Bang (+)

13.40*

Note. BMI = Body Mass Index; M = Mean; SD = Standard Deviation. This table only presents n and %
values for the presence (coded “Yes” = 1) of Primigravida, Pre-Pregnancy BMI ≥ 30 (kg/m2), Chronic
Hypertension, Prior Preeclampsia, Pregestational Diabetes, Prior Cesarean Delivery, and Stop-Bang Score
≥ 3 (+) (high-risk for Obstructive Sleep Apnea).
* p ≤ .05, ** p ≤ .001.
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CHAPTER V
DISCUSSION
In this study two different instruments were used to assess the prevalence of sleep
disordered breathing (SDB) in a general pregnant population presenting for delivery at a
tertiary care military treatment facility (MTF). The overall prevalence of sleep disordered
breathing in the general population at time of delivery using the Facco Four Variable
(FFV) model was 12.3% and 7.1% using STOP-Bang (SB). The FFV is relatively new
and purpose-built for the obstetric population while SB was designed for the preoperative surgical population and is used extensively throughout the military health
system in primary care and anesthesia preoperative clinics. Screening positive for SDB
showed strong associations with gestational hypertension and cesarean delivery–both of
which are morbidities with adverse effects on pregnancy outcomes. Pregnancy is a
biologically active portion of a woman’s life that can have a profound influence on future
health. The inflammation caused by SDB seem to have adverse physiological effects on a
woman’s health and how her infant is delivered. This adds to the significance of our
results and demonstrates a need to improve awareness, interventions for, and further
research of SDB in the pregnant population. As we discovered, a significant percentage
of women are at risk for SDB yet few are aware of this risk. All of the participants who
screened positive were essentially undiagnosed cases of SDB as none had undergone
screening or objective testing for SDB prior to participating in this study. This
“unknown” risk is significant and, at first, surprising. However, SDB is underdiagnosed
and underreported in women–especially during pregnancy (J. Louis, Auckley, & Bolden,
2012). Another concern is the persistence of the SDB diagnosis after delivery. Does the

64

rapid reduction in weight and BMI resolve SDB? What is the relationship of SDB, sleep
fragmentation, and fatigue in the postpartum period? There are many questions that still
need to be investigated about SDB and pregnancy.
The FFV was created, based on the Berlin questionnaire, to screen pregnant
women at high risk for SDB (Facco et al., 2012). Pregnant women at increased risk for
SDB may have chronic hypertension, pre-gestational diabetes, obesity, or prior a history
of preeclampsia. The prevalence of SDB in populations with these risk factors can range
from 15.4% (Pien et al., 2014) to over 45% (Facco et al., 2014). In this study, the FFV
was applied to a general pregnant population and participants were not pre-selected based
on attributes for increased risk of SDB. This is a unique aspect of this study and a new
application for the FFV. Early studies, such as the Wisconsin Sleep Cohort Study
(WSCS, Young, 1993), focused on the general adult population. The WSCS found an
initial prevalence of SDB for adult women was 9%, much higher than the estimated 2%
at the study’s inception, but still significantly less than the 24% prevalence for men
(Young, 1993). The 12.3% prevalence found in our study suggests there may be an
increased amount of SDB during pregnancy, which may be related to the weight gain and
physiological changes of pregnancy which affect airway architecture. Because formal
sleep studies were not performed, we cannot confirm patients enrolled had SDB, and it is
unknown what percentage of them would have SDB symptoms resolve after pregnancy.
It should be noted the first exclusion criteria for the Wisconsin Sleep Cohort Study was
pregnancy and for enrollment the participants were between 30-60 years of age. The
WSCS study was initiated over 20 years ago and the prevalence of obesity and SDB have
since risen dramatically since then (J. M. Louis et al., 2014).
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Increased body weight and body mass index (BMI) figured prominently in the
study reported here. Both instruments include measures of BMI as factors to identify
SDB risk and they highlight the relationship between body weight and SDB in
pregnancy. For women who screened positive with the FFV, more presented with a prepregnancy BMI >30, a larger neck circumference, and had a higher BMI at delivery than
those who screened negative. Using SB, women who screened positive had a higher prepregnancy weight, pre-pregnancy BMI, neck circumference, higher delivery weight and
delivery BMI, and a greater percentage with a pre-pregnancy BMI >30. Complications of
maternal obesity in pregnancy include gestational diabetes, preeclampsia, cesarean
delivery, low apgar scores, and macrosomia (Ovesen et al., 2011). Patients screening
positive on the FFV and SB had significantly higher rates of cesarean delivery, a finding
consistent with obesity in pregnancy.
For this study, a pre-pregnancy BMI >30 was noted in 18.7% of participants
compared to a national prevalence of obesity (BMI ≥ 30%) reported as 35.8% among
adult women (Flegal et al., 2012). Our sample contains 38.5% (n=116) active duty
women who are required to maintain physical fitness and BMI standards as part of their
military service. In addition, all participants have access to high quality healthcare
through the Department of Defense, Military Health System and the study inclusion
criteria required eligibility for care and enrollment in this system. Clinical settings with
higher rates of obesity and possibly with less access to healthcare may have a greater
prevalence of obesity and ultimately, SDB. Based on the results of this study, excess
weight gain and elevated BMI are significant factors in the development of SDB.
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Limitations
Results from this study must be viewed in light of the following limitations. This
study lacks objective verification for the diagnosis of sleep disordered breathing. Both the
FFV and SB are screening tools used to help make decisions about whether further
diagnostic intervention is needed; neither is able to provide more than a suspected range
for an apnea-hypopnea index value. While the FFV has been validated with PSG in a
population at high-risk for SDB it has not been validated in the general obstetric
population. Similarly, while SB has been extensively validated in the surgical population
using PSG, there are limited studies that have been conducted in the obstetric population.
Recently, a study compared SB with the Berlin questionnaire in each trimester of
pregnancy in women recruited from a high-risk antenatal clinic in Thailand (Tantrakul et
al., 2015). A total of 72 women (23 first trimester, 24 second trimester, 25 third
trimester) were recruited, completed both the Berlin and SB questionnaires, and then
given an at-home, wrist worn, overnight sleep study. The authors used a unique cutoff
point of BMI >27.5 for SB that was determined to be culturally specific for their sample.
The study found the sensitivity to identify patients with OSA was poor in the first
trimester (sensitivity = 57.1%, specificity = 87.5%, PPV = 66.7%, NPV = 82.7%, AUC
0.71, p = 0.23, CI 95% = 0.47-0.92), improved in the second trimester (sensitivity =
62.5%, specificity = 93.8%, PPV = 83.3%, NPV = 83.3%, AUC 0.78, p = 0.23, CI 95% =
0.47-0.92), and decreased in the third trimester (sensitivity = 62.5%, specificity = 88.2%,
PPV = 71.4%, NPV = 83.3%, AUC 0.75, p = 0.04, CI 95% = 0.53-0.97). The high
specificity in all three trimesters suggests patients who screened positive most likely had
OSA, but the moderate sensitivity suggests we cannot be certain if a patient screened
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negative that they do not have OSA. The positive predictive value was the highest in the
second trimester, with 83.3% screening SB positive having confirmed OSA based on an
apnea hyponea index (AHI) ≥5 events per hour. This suggests the second trimester may
be the best time to screen women for OSA; however, earlier screening during the first
trimester may allow for earlier intervention. The decrease in the positive predictive value
in the third trimester is somewhat counterintuitive given that weight gain during
pregnancy, in the majority of cases, will increase until delivery. It would be expected that
symptoms of SDB would peak during the third trimester with maximum weight, BMI,
and symptoms occuring at delivery and most easily recognized. Comparatively, a recent
study by Facco et al. (2014), found the prevalence of SDB increased during pregnancy
among a cohort of women at high-risk for SDB. A prospective observational study
involving 128 women screened as high-risk for developing SDB underwent an at-home
sleep study at 6-20 weeks gestation and repeated in the third trimester. Worsening or
increasing severity of SDB during pregnancy was noted in 27% of the population and the
incidence of new-onset SDB was 20%. One explanation for this difference may be that
in the Tantrakul et al. (2015) study, a single cohort of women was not followed
throughout pregnancy. The dynamic process and continuous changes throughout
pregnancy may require continuous monitoring and screening for optimal risk assessment
regardless of the instrument used. The SB instrument, well known for ease of use and
reliability in the surgical population, will require further validation and refinement for use
during pregnancy.
Self-reporting of symptoms and co-morbidities is another limitation of this study.
Participants were asked to self-report the loudness of their snoring and the presence of
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apneic episodes that occur while the participant is asleep. The case report form included
questions to elicit a bed partner or roommate’s assessment of snoring and apneic
episodes. Overall, 90.3% of respondents reported having a bed partner, 3% reported a
partner/roommate in another room, and 6.7% reported no bed partner or roommate at all.
Participants were not monitored during completion of the case report form and bed
partner or roommate participation was not verified. There is some evidence of
disagreement in which the self-report was negative for symptoms while the bed partner’s
report was positive for symptoms and vice-versa. Without direct engagement of the bed
partner or roommate it is difficult to ascertain their involvement in the completion of the
case report form and accuracy of responses. An objective and quantifiable measure of
SDB, such as an at-home sleep study, would have greatly strengthened the results.
There are several types of hypertension during pregnancy: chronic hypertension,
preeclampsia-eclampsia, chronic hypertension with superimposed preeclampsia,
gestational hypertension, and postpartum hypertension (American College of
Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy & American
College of Obstetricians and Gynecologists, 2013). For this study, only chronic
hypertension prior to pregnancy was used in scoring of the instruments. Both the FFV
and SB instruments are derived from the Berlin questionnaire to screen for SDB/OSA but
in different populations. FFV focused on women at high risk for SDB during pregnancy
and SB for OSA in the surgical population (Chung et al., 2008b; Facco et al., 2012). The
Berlin Questionnaire uses chronic hypertension as a factor in screening for OSA and was
designed for primary care settings (Netzer, Stoohs, Netzer, Clark, & Strohl, 1999). This
methodology has been carried over in the wording of both instruments in this study as
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“chronic hypertension” and “high blood pressure” were used in the case report form
without discussion of “preeclampsia-eclampsia” or “gestational hypertension”. The
diagnosis of chronic hypertension came from the physician’s history and physical as
reported in the medical record. Including gestational hypertension and preeclampsia in
this study most likely would have resulted in a greater percentage of women screened as
“positive” for SDB, but not necessarily improved the sensitivity and specificity of the
instruments. Chronic hypertension has a different physiologic mechanism than
gestational hypertension and preeclampsia despite the common outcome of elevated
systemic blood pressure. This may have been the reason for the decreased sensitivity of
SB noted by Tantrakul et al (2015). Of the 72 women enrolled, 13 (18.1%) had
hypertension. However, chronic hypertension was diagnosed in just 2 participants while
11 were diagnosed with preeclampsia. There may still be a relationship between SDB and
the hypertensive disorders of pregnancy. Future studies should include methodology to
parse out such differences.
Despite these limitations, findings from this study advances our understanding of
strategies for screening for SDB during pregnancy. Overall, the study found a prevalence
of SDB by the Facco Four Variable Model of 12.3% and 7.1% by the STOP-Bang model
in the general pregnant population presenting for delivery at a large military treatment
facility. Strong associations with cesarean delivery and gestational hypertension were
noted. Obesity continues to play a role in SDB as those who screened positive with either
model were more likely to have elevations of weight and or BMI both in the beginning of
pregnancy and at delivery. The study population was unique with 38.5% active duty
military members who are required to meet specific health requirements for weight and
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BMI. The prevalence of obesity was almost half of a national estimate and all of the
participants had access to high quality healthcare throughout pregnancy.
Conclusion
Routine screening for SDB during pregnancy utilizing the FFV model should be
conducted. Increased awareness of SDB and the effects of sleep on overall health is noted
in scientific and popular literature. In the past, a lack of screening tools specific to the
population under study and the use of clinic-based polysomnography (PSG) were
obstacles that had to be overcome in order to diagnose and treat SDB. New technology
has brought the ability to conduct at-home sleep studies that rival clinic based PSGpossibly the most important recent advance in sleep medicine. The at-home monitors are
less expensive, applied by the patient, and physically less of a burden to sleep with
(Facco et al., 2012). These new devices may facilitate research by providing more
objective, quantifiable information about SDB. An at-home testing device could facilitate
the development of more accurate screening instruments, a lower threshold for testing,
earlier detection and the opportunity for repeated testing to track progression, treatment,
and resolution of SDB. Further research is needed to determine critical points in the
development and management of SDB during pregnancy, if or when SDB resolves after
delivery, and the long-term health effects that may occur for both mother and child.

71

REFERENCES

American College of Obstetricians and Gynecologists. Task Force on Hypertension in
Pregnancy, & American College of Obstetricians and Gynecologists. (2013).
Hypertension in pregnancy. Washington, DC: American College of Obstetricians
and Gynecologists.
Beebe, K. R., & Lee, K. A. (2007). Sleep disturbance in late pregnancy and early labor. J
Perinat Neonatal Nurs, 21(2), 103-108.
doi:10.1097/01.JPN.0000270626.66369.26
Bourjeily, G., Ankner, G., & Mohsenin, V. (2011). Sleep-disordered breathing in
pregnancy. Clin Chest Med, 32(1), 175-189, x. doi:10.1016/j.ccm.2010.11.003
Chung, F., & Elsaid, H. (2009). Screening for obstructive sleep apnea before surgery:
why is it important? Curr Opin Anaesthesiol, 22(3), 405-411.
doi:10.1097/ACO.0b013e32832a96e2
Chung, F., Yegneswaran, B., Liao, P., Chung, S. A., Vairavanathan, S., Islam, S., . . .
Shapiro, C. M. (2008a). STOP questionnaire: a tool to screen patients for
obstructive sleep apnea. Anesthesiology, 108(5), 812-821.
Chung, F., Yegneswaran, B., Liao, P., Chung, S. A., Vairavanathan, S., Islam, S., . . .
Shapiro, C. M. (2008b). STOP questionnaire: a tool to screen patients for
obstructive sleep apnea. Anesthesiology, 108(5), 812-821.
doi:10.1097/ALN.0b013e31816d83e4

72

Dodd, M., Janson, S., Facione, N., Faucett, J., Froelicher, E. S., Humphreys, J., . . .
Rankin, S. (2001). Advancing the science of symptom management. Journal of
advanced nursing, 33(5), 668-676.
Facco, F. L., Ouyang, D. W., Zee, P. C., & Grobman, W. A. (2012). Development of a
pregnancy-specific screening tool for sleep apnea. J Clin Sleep Med, 8(4), 389394. doi:10.5664/jcsm.2030
Facco, F. L., Ouyang, D. W., Zee, P. C., & Grobman, W. A. (2014). Sleep disordered
breathing in a high-risk cohort prevalence and severity across pregnancy. Am J
Perinatol, 31(10), 899-904. doi:10.1055/s-0033-1363768
Flegal, K. M., Carroll, M. D., Kit, B. K., & Ogden, C. L. (2012). Prevalence of obesity
and trends in the distribution of body mass index among US adults, 1999-2010.
JAMA, 307(5), 491-497. doi:10.1001/jama.2012.39
Gottlieb, D. J. (2008). The Sleep Heart Health Study: a progress report. Current opinion
in pulmonary medicine, 14(6), 537-542.
Guilleminault, C., Tilkian, A., & Dement, W. C. (1976). The sleep apnea syndromes.
Annu Rev Med, 27, 465-484. doi:10.1146/annurev.me.27.020176.002341
Johns, M. W. (1991). A new method for measuring daytime sleepiness: the Epworth
sleepiness scale. Sleep, 14(6), 540-545.
Louis, J., Auckley, D., & Bolden, N. (2012). Management of obstructive sleep apnea in
pregnant women. Obstet Gynecol, 119(4), 864-868.
doi:10.1097/AOG.0b013e31824c0c2f
Louis, J., Auckley, D., Miladinovic, B., Shepherd, A., Mencin, P., Kumar, D., . . .
Redline, S. (2012). Perinatal outcomes associated with obstructive sleep apnea in

73

obese pregnant women. Obstet Gynecol, 120(5), 1085-1092.
doi:http://10.1097/AOG.0b013e31826eb9d8
10.1097/AOG.0b013e31826eb9d8
Louis, J. M., Auckley, D., Sokol, R. J., & Mercer, B. M. (2010). Maternal and neonatal
morbidities associated with obstructive sleep apnea complicating pregnancy. Am J
Obstet Gynecol, 202(3), 261 e261-265. doi:10.1016/j.ajog.2009.10.867
Louis, J. M., Mogos, M. F., Salemi, J. L., Redline, S., & Salihu, H. M. (2014).
Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the
United States, 1998-2009. Sleep, 37(5), 843-849. doi:10.5665/sleep.3644
Netzer, N. C., Stoohs, R. A., Netzer, C. M., Clark, K., & Strohl, K. P. (1999). Using the
Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann
Intern Med, 131(7), 485-491. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/10507956
Ovesen, P., Rasmussen, S., & Kesmodel, U. (2011). Effect of prepregnancy maternal
overweight and obesity on pregnancy outcome. Obstet Gynecol, 118(2 Pt 1), 305312. doi:10.1097/AOG.0b013e3182245d49
Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W., & Hla, K. M. (2013).
Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol,
177(9), 1006-1014. doi:10.1093/aje/kws342
Pien, G. W., Pack, A. I., Jackson, N., Maislin, G., Macones, G. A., & Schwab, R. J.
(2014). Risk factors for sleep-disordered breathing in pregnancy. Thorax, 69(4),
371-377. doi:10.1136/thoraxjnl-2012-202718

74

Quan, S. F., Howard, B. V., Iber, C., Kiley, J. P., Nieto, F. J., O'Connor, G. T., . . . Wahl,
P. W. (1997). The Sleep Heart Health Study: design, rationale, and methods.
Sleep, 20(12), 1077-1085. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/9493915
Sahin, F. K., Koken, G., Cosar, E., Saylan, F., Fidan, F., Yilmazer, M., & Unlu, M.
(2008). Obstructive sleep apnea in pregnancy and fetal outcome. Int J Gynaecol
Obstet, 100(2), 141-146. doi:10.1016/j.ijgo.2007.08.012
Sultan, P., Gutierrez, M. C., & Carvalho, B. (2011). Neuraxial morphine and respiratory
depression: finding the right balance. Drugs, 71(14), 1807-1819.
doi:10.2165/11596250-000000000-00000
Tantrakul, V., Sirijanchune, P., Panburana, P., Pengjam, J., Suwansathit, W.,
Boonsarngsuk, V., & Guilleminault, C. (2015). Screening of obstructive sleep
apnea during pregnancy: differences in predictive values of questionnaires across
trimesters. J Clin Sleep Med, 11(2), 157-163. doi:10.5664/jcsm.4464
Young, T. (1993). The occurence of sleep-disordered breathing among middle-aged
adults. The New England Journal of Medicine.
doi:10.1056/NEJM199304293281704
Young, T., Finn, L., Peppard, P. E., Szklo-Coxe, M., Austin, D., Nieto, F. J., . . . Hla, K.
M. (2008). Sleep disordered breathing and mortality: eighteen-year follow-up of
the Wisconsin sleep cohort. Sleep, 31(8), 1071-1078. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/18714778

75

Young, T., Peppard, P. E., & Gottlieb, D. J. (2002). Epidemiology of obstructive sleep
apnea: a population health perspective. Am J Respir Crit Care Med, 165(9), 12171239. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11991871

76

NAVMED 5721/1 (Rev.
10-2009)

Page 2
of 2

77

78

